PODCAST · business
Beginner's Mind
by Christian Soschner
Blueprints for Builders and InvestorsHosted by Christian SoschnerFrom pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech—lives or dies by the frameworks it follows.On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds.With over 250 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast. With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:What it really takes to turn breakthrough science into business—how to grow it, lead it, and shape the world around it.
-
221
Alasdair Milton, KPMG | Why Precision Medicine Still Fails Patients (SPARK20 – 168)
Only one in three eligible lung cancer patients receives the targeted therapy they should get.That is not a failure of science.It is a failure of delivery.After more than two decades of precision oncology, biopharma has never had better tools: cell and gene therapy, in vivo CAR-T, antibody-drug conjugates, AI-enabled diagnostics, organoids, multi-omics, and global clinical data.Yet too many breakthroughs still fail to reach the bedside.Patients fall through fragmented systems.Data does not move cleanly.Community oncologists are overloaded.Tests are missed, delayed, or misread.Promising assets die in quarterly portfolio reviews.And healthcare systems built for pills, tablets, and chronic disease management are now being asked to deliver personalized medicine at scale.In this SPARK20 highlight episode, Alasdair Milton, PhD, Principal at KPMG and leader of the firm’s Precision & Advanced Therapies practice, explains why the future of biopharma will not be decided by science alone.It will be decided by translation.From lab bench to boardroom.From data to decisions.From treatment to prevention.Alasdair brings more than 20 years of experience across life sciences strategy, commercial due diligence, precision medicine, advanced therapies, cell and gene therapy, biopharma M&A, diagnostics, and global healthcare transformation.This conversation moves from the precision medicine delivery crisis to China’s biotech acceleration, from AI and organoids to trapped pharma assets, from lifelong wellness to the one skill every future biotech leader needs:The ability to translate complex science into business strategy, capital allocation, and patient impact.What You’ll Learn in 22 MinutesWhy only one third of eligible lung cancer patients receive targeted therapy(00:01:53)And why precision medicine still breaks in everyday clinical practice.Why science keeps compounding even when systems fail(00:04:33)Including in vivo CAR-T, functional cures, gene therapy, and antibody-drug conjugates.Why innovation does not move in a straight line(00:05:20)How technologies can look dead for years before suddenly changing the market.Why China’s biotech speed matters(00:07:36)How AI, organoids, scale, and execution are changing the global innovation map.Why great science dies inside Big Pharma(00:09:20)And how deprioritized assets can become billion-dollar companies when externalized properly.Why the industry must move from sickness to lifelong wellness(00:10:03)Alasdair’s vision for a more proactive, preventive, data-driven healthcare system.Why pharma needs better ways to rescue shelved assets(00:13:06)Including examples such as SpringWorks, Cerevel, and new models for unlocking trapped value.How a 400-person Scottish island shaped Alasdair’s worldview(00:15:07)The personal story behind his resilience, discipline, and leadership style.Why careers and companies are never linear(00:17:19)What Alasdair learned after moving to Boston and losing his role within weeks.Why the future belongs to translators(00:20:06)The most valuable skill in biotech: explaining complex science to business leaders, investors, and boards.How to connect with Alasdair Milton and the KPMG Precision & Advanced Therapies team(00:21:47)Quotes to Carry With You📌 “We’ve been doing precision medicine in lung cancer for decades, over two decades, and we’re still not getting it right.” (00:01:53)📌 “This is where this incredible world of genomic science bumps up against the realities of everyday clinical practice.” (00:03:31)📌 “When I was doing my PhD 28 years ago, the idea that you could even have a targeted cell therapy was almost like science fiction.” (00:04:41)📌 “The speed was just astonishing.” (00:07:47)📌 “We’ve been a sickness industry. We’ve treated disease, chronic disease. But can we move more towards lifelong wellness and preemptive health?” (00:10:03)📌 “There’s not a systematic way to collect all of the incredible science and incredible assets that go on the shelf every quarter.” (00:13:06)📌 “There’s great science that never sees the light of day because it’s killed in a quarterly portfolio review.” (00:15:00)📌 “Your career is never linear.” (00:17:19)📌 “You have to be able to build the bridge between the lab and the business world.” (00:20:06)Why This Conversation MattersPrecision medicine is often described as the future of healthcare.But the future does not arrive because the science is ready.It arrives when diagnostics, data, reimbursement, clinical workflows, manufacturing, capital, leadership, and incentives finally work together.That is the real challenge now facing biopharma.Not whether innovation can happen. It already is.The question is whether leaders can build the systems that allow innovation to reach patients.Alasdair Milton is one of the rare voices who can explain that challenge across science, strategy, capital, and execution.If you are a founder, investor, operator, scientist, board member, policymaker, or family office looking at the future of biotech, precision medicine, advanced therapies, pharma M&A, AI in healthcare, or China’s rise in biopharma, this episode is worth your time.👉 Listen now.Share it with someone building the future of medicine.Follow Beginner’s Mind for more conversations with the people shaping biotech, capital, and healthcare.Topics: precision medicine, biopharma, biotech, KPMG, Alasdair Milton, cell and gene therapy, in vivo CAR-T, targeted therapy, lung cancer, oncology, AI in healthcare, organoids, China biotech, pharma M&A, SpringWorks, Cerevel, advanced therapies, diagnostics, translational science, venture capital, healthcare strategy.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
220
#176 - Why Smart People Say Yes: 7 Lessons from Influence by Robert Cialdini
Some books explain how the world works.Influence explains why people move.Why someone takes the meeting.Why an investor leans in.Why a customer trusts.Why a team follows.Why a board stays stuck.Why a founder keeps defending a decision that stopped making sense months ago.Robert Cialdini’s Influence: The Psychology of Persuasion is one of those books that becomes more valuable the longer you build, invest, sell, negotiate, hire, and lead.Because at some point, you realize something uncomfortable:Most decisions are not made after perfect analysis.They are made under pressure.With incomplete information.With too many options.Too little time.And a nervous system looking for shortcuts.That is where Cialdini’s work becomes powerful.He shows that human beings rely on recurring decision triggers: reciprocation, liking, social proof, authority, scarcity, commitment and consistency, and unity.These are not tricks.They are part of the operating system of human behavior.And if you build or invest in companies from Series A to IPO and beyond, these forces are everywhere.They show up in fundraising.In sales.In hiring.In pricing.In board meetings.In investor updates.In partnerships.In leadership.And in the quiet signals people read before they ever say yes or no.A founder can have the better product and still lose because nobody trusts the signal.A CEO can have the right strategy and still fail because the team never feels real unity.An investor can see the data and still follow the crowd because social proof feels safer than independent judgment.A service provider can have rare expertise and destroy their own value by being too available.A board can keep supporting a flawed decision because everyone wants to stay consistent with what they already said.That is why this book matters.Not because it teaches manipulation.But because it teaches respect for human nature.The best builders do not work against psychology.They work with it.They understand that a small act of generosity can open a door.That people need to like you before they seriously negotiate with you.That visible proof often matters before deep proof gets examined.That authority begins before you speak.That scarcity protects value.That commitment can create momentum — or trap you.And that the strongest companies often feel less like transactions and more like “we.”In this episode, I translate Cialdini’s seven principles into practical lessons for founders, CEOs, investors, and operators building companies in the real world.Not as abstract psychology.As boardroom practice.As fundraising practice.As sales practice.As leadership practice.As reputation practice.And as a defense system against being influenced by people who understand these principles better than you do.What We CoverReciprocation Why small, right-sized generosity works better than aggressive asking.Liking Why manners, presence, and positive repeated contact still matter more than most people admit.Social Proof Why people judge you by the company you keep — and why markets often follow visible signals before they examine fundamentals.Authority Why titles, suits, posture, calmness, and credibility shape decisions before logic enters the room.Scarcity Why unlimited availability destroys value — and why thoughtful limits can increase demand.Commitment and Consistency Why small yeses become large decisions, and why founders must learn to ask: “Knowing what I know now, would I still choose this?”Unity Why the deepest form of influence is not persuasion, but the feeling that “we are in this together.”Timestamps(00:00) Introduction(02:05) Big Idea – Instant Influence: Primitive Consent for an Automatic Age(05:35) Author’s Background(07:38) Reciprocation – The Old Give and Take… and Take(13:34) Liking – The Friendly Thief(18:55) Social Proof – Truths Are Us(24:41) Authority(32:10) Scarcity – The Rule of the Few(38:00) Commitment and Consistency – Hobgoblins of the Mind(45:00) Unity – We-Ness and the Power of Shared Identity(51:19) Key Takeaways(53:53) Personal Reflection(56:18) Final WordsWhy This Episode MattersIf you raise capital, this episode helps you understand why investors lean in before they fully understand the deck.If you sell, it helps you see why trust is often built before the formal pitch begins.If you lead, it helps you design cultures where people commit because they identify with the mission, not because they were told to comply.If you invest, it helps you protect yourself against false signals: fake authority, fake scarcity, fake social proof, and beautifully packaged nonsense.And if you build companies, it reminds you of something simple:Human nature is not a side issue.It is the terrain.The best founders, investors, and leaders learn to read it.Because capital does not move only toward logic.People do.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
219
EP 175: Stefanie Schubert | Why Smart People Lose Negotiations Before They Start
Most leaders think negotiation begins when both sides sit down to talk numbers. By then, trust, incentives, timing, internal alignment, and first impressions have already shaped the outcome. That is why smart founders, executives, investors, and board members can have the right facts and still walk away with the wrong result.In this episode of Beginner’s Mind, Stefanie Schubert explains why negotiation is not a last-minute performance at the table. It is a leadership capability that starts much earlier, in the way people prepare, build trust, frame value, listen, manage emotions, and understand what the other side truly needs.Stefanie is a Professor of Economics at SRH University Heidelberg, a Negotiation Advisor, Keynote Speaker, and ICF-certified Executive Coach. Her work combines behavioral economics, game theory, negotiation, executive coaching, and real-world business practice, with experience in complex business environments, alliance management, and biopharma. This conversation moves from the practical to the profound: why intelligent people still make weak decisions, why preparation often matters more than persuasion, why pushing people creates resistance, how ballroom dancing explains negotiation better than many textbooks, and why investors, scientists, founders, and corporate leaders often speak past each other without realizing it.We also explore John Nash, A Beautiful Mind, first offers, anchoring, emotional decision-making, AI-driven profiling, trust in virtual environments, and why rejection in fundraising is not necessarily the end of the negotiation.As Stefanie puts it:(01:50:33) “You bring in something. It’s not that you beg for money with the investor.”That may be the core lesson of the episode.Good negotiation is not domination. It is not theatre. It is not a bag of tricks. It is the discipline of understanding value, shaping the game, and entering the room with enough clarity to build something useful with another person.Selected moments(00:00:00) Why smart people lose negotiations early(00:04:24) Negotiation starts before the table(00:07:57) Why smart people still decide poorly(00:13:25) Influence creates value not manipulation(00:18:21) Human shortcuts quietly kill opportunities(00:25:08) Ballroom dancing reveals negotiation resistance(00:28:44) Active listening creates leadership leverage(00:34:06) Authenticity beats dominance in leadership(00:37:05) How to de-escalate emotional negotiations(00:45:05) Game theory without mathematical intimidation(00:52:57) A Beautiful Mind and collaboration traps(01:00:47) First offers and anchoring pressure(01:06:37) Internal alignment before external negotiation(01:12:25) Why emotions can be rational(01:17:20) Fast thinking versus sustainable judgment(01:32:25) AI profiling can poison first impressions(01:40:59) Trust building before formal deals(01:45:04) Why investor rejection is not final(01:47:24) Designing negotiations from first contact(01:48:11) Create value before dividing value(01:50:28) Confidence before asking for capitalFollow Beginner’s Mind for long-form conversations on leadership, capital, technology, negotiation, and the people shaping what comes next.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
218
EP 174: Wanwipa Siriwatwechakul | Funding the Next Industrial Era
Most people still treat climate solutions as a cost.Wanwipa Siriwatwechakul argues that this is exactly why so many leaders miss the real opportunity.The next industrial era will not be built by patching old systems, but by redesigning them from the ground up.In this episode of Beginner’s Mind, Wanwipa explains why industrial decarbonization is not mainly about sacrifice, compliance, or adding expensive fixes to yesterday’s infrastructure. It is about building better systems, stronger companies, and entirely new categories of value creation.A chemical engineer trained at MIT and Princeton, former professor, and Partner at Vectors Capital, Wanwipa works at the intersection of climate tech, synthetic biology, industrial innovation, and early-stage venture capital. Her perspective is grounded in both science and scale: what matters is not only whether a breakthrough works in the lab, but whether it can survive the journey from one gram to one ton, from prototype to product, from curiosity to adoption.We talk about why the strongest climate companies redesign industries instead of decorating old ones, why synthetic biology is emerging as a new industrial toolkit, how startups like Huue Bio, Ingrediome, and Solidec reveal very different scale-up strategies, and why the best founders treat breakthroughs as hypotheses to test rather than theories to defend.As Wanwipa puts it:(01:57:02) “See climate solutions not as cost, but as funding the next industrial era.” What you’ll hear in this episodeWhy decarbonization becomes far more powerful when industries are redesigned, not merely optimized How synthetic biology can replace toxic, waste-heavy industrial chemistry with cleaner production models Why great science is only the starting point, and why scale is where most companies really live or die What founders can learn about resilience, coachability, timing, and relentless customer discovery How climate tech can create competitive advantage, new revenue streams, and distributed industrial resilience Why Southeast Asia may become a powerful region for the next wave of climate and bioindustrial growth Selected moments(00:00:56) From Professor to Climate Tech Venture Capital(00:09:27) Why Climate Change Became Personal in Thailand(00:14:11) From Pure Discovery to Real Market Impact(00:23:00) Decarbonization by Redesigning Industry(00:30:06) The Climate Tech Mistake Costing Investors Money(00:34:17) Solidec and the Future of Distributed Manufacturing(00:38:50) Why Big Companies Resist Industrial Reinvention(00:46:21) How Great Founders Turn Pivots Into New Markets(00:50:50) Customer Discovery in Deep Tech and Climate Startups(00:53:08) Great Science Must Become Products People Use(01:00:39) Synthetic Biology as the New Industrial Toolkit(01:10:15) How Climate Startups Find Early Adopters(01:13:19) Founder Resilience and the Stomach of Steel(01:21:15) Venture Capital and the Crucial Why Now(01:57:02) Climate Solutions as Funding the Next Industrial Era Follow the show for more long-form conversations on technology, capital, leadership, and the people shaping what comes next.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
217
EP 173: Bret Kugelmass | The West Bet on the Wrong Energy Future
Power demand is rising faster than the systems meant to support it.AI, electrification, and industry all need stable energy, but the dominant story sold to the public was far simpler than reality. In this episode, Bret Kugelmass explains why the real bottleneck was never just climate ambition, but how the West misunderstood energy itself.For years, nuclear was framed as too dangerous, too slow, too expensive, and politically untouchable. Meanwhile, electricity demand kept rising, industrial resilience became strategic again, and the gap between energy ambition and physical reality widened.This conversation gets underneath the narrative. (Recorded November 2023)Bret Kugelmass, Founder and CEO of Last Energy, argues that the nuclear debate was never only about science or safety. It was also about incentives, regulation, public perception, delivery models, and the failure to distinguish what is inherent to the technology from what is imposed by the system around it.Drawing on his path from Silicon Valley entrepreneurship into deep energy infrastructure, Bret explains why he believes the West solved for the wrong variables, why wind and solar alone cannot carry modern industrial societies in many regions, and why the real breakthrough in nuclear may not come from reinventing the reactor, but from reinventing how power plants are built, sold, and deployed.As he puts it: (00:33:11) “Solve the wrong problem brilliantly and you’ll be the only one who cares.”This episode is not just about nuclear energy. It is about first-principles thinking, product-market fit in deep tech, and the kind of contrarian founder logic required to build where politics, infrastructure, and capital collide.What You’ll Learn in This Episode 1️⃣ Why Bret says the West misunderstood the real energy bottleneck 2️⃣ Why net zero may be the wrong framing for climate ambition 3️⃣ What most people still get wrong about nuclear waste, safety, and Fukushima 4️⃣ Why nuclear’s real challenge is cost and construction, not physics 5️⃣ How Last Energy reframed the business by selling electricity, not reactors 6️⃣ What founders can learn from solving the right problem before scalingSelected Timestamps (00:04:29) Introduction (00:04:29) Defining climate goals beyond net zero (00:13:46) Bret discovers nuclear mission and truth (00:19:44) Chernobyl versus Fukushima what truly matters (00:21:39) Nuclear's unmatched physics for abundant energy (00:30:08) Ideal world nuclear plants in 18 months (00:36:02) Solving the right problem before building (00:42:58) First principles simplicity as Last Energy’s edge (00:51:16) Securing 30 billion through true product market fit (00:54:05) Last Energy vision for tens of thousands of gigawatts (00:56:12) Taking ultimate responsibility to drive massive global progress🎙️ Beginner’s Mind Top 10% globally. Conversations for founders, investors, executives, and policymakers shaping biotech, deep tech, energy, and industrial transformation.Follow the show for more long-form conversations on technology, capital, and the people building what the future wilSend us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
216
#172 - Fast Forward Thinking: Why Most Investments Fail — And How Elite VCs Think Differently
Most investors think they’re rational.Most founders think they’re disciplined.Most boards think they’re strategic.They’re usually wrong.In this episode, we unpack Fast Forward Thinking by Luis Pareras — a physician turned deep-tech venture capitalist who distilled decades of investing under scientific uncertainty into 40 brutally structured rules.This is not a summary.It’s a decision upgrade for founders, operators, board members, and capital allocators navigating the high-stakes terrain from Series A to IPO and beyond — where bias compounds, capital misallocates, and timing determines survival.Across seven tightly structured lessons, we explore how elite investors actually think:Why consensus is often a red flagWhy opportunity abundance demands ruthless selectivityWhy the first meeting should never closeWhy innovation compounds through milestones — not miraclesWhy exit logic must exist from day oneWhy managing error asymmetry beats being “right”And why teams — not ideas — determine survival under pressureThis episode translates Pareras’ venture logic into executive practice — with direct applications for capital allocation, hiring, governance, and strategic design.You’ll walk away with frameworks, sharper filters, and board-level questions that immediately improve judgment.Key TakeawaysBias Is the Silent Capital Killer Consensus feels safe. It often destroys upside.Selectivity Is Survival Abundance demands disciplined rejection.Curiosity Beats Closure The first meeting earns the second.Innovation Is Staged Breakthroughs are milestone-based progressions.Exit Thinking Is Structural Capital is deployed against time horizons.Error Asymmetry Shapes Returns Managing Type I and Type II errors defines long-term performance.Teams Outperform Ideas Execution discipline and cognitive flexibility win under uncertainty.Timestamps(00:00) Introduction(04:17) The Big Idea(08:33) Who Is Luis Pareras(12:03) Takeaway 1: Cognitive Bias Is the Hidden Enemy of Good Decisions(18:55) Takeaway 2: Deal Flow Is Abundant — Selectivity Is the Real Skill(24:16) Takeaway 3: The First Meeting Is Not About Closing(29:04) Takeaway 4: Innovation Is a Process(35:20) Takeaway 5: Exit Awareness Shapes Investment Logic(39:59) Takeaway 6: Error Types Matter More Than Individual Outcomes(44:38) Takeaway 7: Teams and Judgment Matter More Than Ideas(49:15) Key Takeaways: The Fast Forward Operating System(54:25) Personal Reflection and EndWhy ListenUpgrade how you evaluate opportunities — before committing capital.Sharpen how you structure innovation — before chasing breakthroughs.Design decision systems that reduce catastrophic error.And build organizations that survive uncertainty.If this episode sharpens your thinking:Follow the show.Share it with someone who allocates capital.And bring these questions into your next board meeting.Because in venture, public markets, and corporate strategy alike —returns are rarely accidental.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
215
EP 171 - Björn Cochlovius: Why Brilliant Biotech Breaks at Manufacturing
Most biotech breakthroughs don’t fail in the lab.They fail when science meets manufacturing reality.And by the time this bottleneck appears, tens of millions are already sunk.This episode examines the most under-discussed failure point in modern biotech: the gap between scientific discovery and scalable, usable healthcare solutions.While science has never been stronger—and big pharma excels at market access—companies that can translate breakthrough biology into industrialized medicines remain rare. Manufacturing, regulation, clinical design, usability for patients and physicians, and global scalability still form a narrow bottleneck where most value is lost.In this conversation, Björn Cochlovius, CEO of Eleva, explains why so many promising biologics fail late—and how Eleva deliberately built a platform designed not to replace existing systems, but to rescue projects that would otherwise be abandoned.Drawing on decades across immunology, biotech leadership, and translational medicine, Björn offers a grounded, operator-level view on what it actually takes to move from elegant science to real-world impact.As he puts it:(00:28:59) “In biotech, courageous decisions often look wrong—until years later.”This discussion goes beyond manufacturing alone. It explores why turning scientific concepts into ready-to-deploy healthcare solutions—complete with clinical data, regulatory pathways, scalable production, and high usability—remains one of the hardest industrial challenges of our time.What You’ll Learn in This Episode1️⃣ Why biologics often fail late—after science already worked2️⃣ Why manufacturing is only one part of a deeper industrial bottleneck3️⃣ How Eleva approaches risk when others walk away4️⃣ Why courage, not optimization, drives breakthrough biotech decisions5️⃣ How AI supports discovery—without replacing human judgment6️⃣ What Europe gets right—and still gets wrong—about scaling biotech🧭 Selected Timestamps(00:03:00) Why biotech breakthroughs fail at manufacturing(00:07:18) Three takeaways for founders and investors short on time(00:08:36) Why biologics production breaks at scale(00:11:41) Salvaging proteins that standard systems cannot produce(00:15:27) The hidden opportunity in “failed” proteins(00:17:21) Why late-stage manufacturing failure destroys value(00:19:35) Why Eleva builds its own pipeline, not just a platform(00:22:46) Glycosylation as a source of better efficacy(00:27:03) Courageous decisions when everyone else has failed(00:30:04) Risk management through parallel scientific bets(00:32:08) Why similar proteins behave differently in patients(00:37:08) AI as a tool, not a replacement for human judgment(00:41:02) Why humans must remain accountable in drug discovery(00:44:25) The tension between basic research and development(00:46:01) Managing the handover between scientific universes(00:50:38) The CEO’s real job: building teams smarter than yourself(00:53:11) Leadership humility and protecting the team(00:56:11) How leaders recharge under long-term pressure(00:59:13) Europe’s biotech bottleneck and why there is still hope(01:02:20) Final reflection: turning science into systems that scale🎙️ Beginner’s Mind Top 10% globally. Conversations for founders, investors, executives, and policymakers shaping the future of biotech, deep tech, and healthcare.Follow the show for more episodes where science meets strategy—and leadership determines what actually scales.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
214
EP 170 - Jim Pulcrano: Why Most Venture Capital Fails And What Europe Still Gets Wrong
Nine out of ten startups fail, yet Europe keeps funding them the same way.Governments replace judgment with bureaucracy, capital replaces experience, and failure is misunderstood instead of learned from.This conversation exposes why venture capital is a profession, not a policy tool — and why getting this wrong quietly kills innovation.In this episode, Jim Pulcrano, Adjunct Professor at IMD and longtime venture investor, explains why most venture capital systems fail before capital is even deployed.Drawing on four decades across Silicon Valley, Europe, and academia, Jim dismantles the myth that VC success comes from spreadsheets, credentials, or government programs. Instead, he shows why pattern recognition, lived experience, and exposure to failure are the real differentiators.As Jim puts it:(01:13:27) “Silicon Valley is the world’s capital of failure — and also the capital of learning.”That mindset difference explains why Europe struggles to scale founders, why governments unintentionally create zombie companies, and why operators consistently outperform theorists when backing the next generation of companies.This is not a motivational episode. It’s a structural diagnosis of how innovation ecosystems actually work — and where Europe still gets in its own way.💡 What You’ll Learn in This Episode1️⃣ Why most venture capital fails long before money is invested2️⃣ Why governments cannot replace judgment, experience, or risk-taking3️⃣ Why operators outperform bankers as investors4️⃣ Why failure is data — not stigma — in high-performing ecosystems5️⃣ What Europe must change to unlock its next innovation cycle👤 About Jim PulcranoJim Pulcrano is an Adjunct Professor at IMD with over four decades of experience across venture capital, entrepreneurship, and executive education. He has worked extensively in Silicon Valley and Europe, advising founders, investors, and institutions on scaling companies, leadership development, and venture capital as a professional discipline.💬 Quotes (01:13:27) “Silicon Valley is the world’s capital of failure — and also the capital of learning.” (01:33:58) “You have to be there at midnight when you’re trying to make a decision on Sunday night.” (01:40:14) “I’ve never met a successful entrepreneur who hasn’t been weeks from running out of money.” (01:23:21) “A government purchase order is worth more than the same amount in cash.”🧭 Timestamps(00:04:25) Why most startups fail — and why that’s not the real problem (00:09:55) Why Europe still misunderstands venture risk (00:16:42) Why founders matter more than ideas (00:24:13) Why governments create zombie startups (00:32:34) Why operator VCs outperform financial engineers (00:40:14) Failure as data, not disgrace (00:48:26) Why venture capital cannot be taught without simulation (01:04:48) What LPs should really look for in fund managers (01:19:46) Government as customer vs government as controller (01:30:10) Why young people should not rush into VC (01:32:38) Why empathy separates great investors from average ones (01:45:13) Leadership shifts from startup to scale-up (01:50:06) Three changes Europe must make now🎙️ Beginner’s MindTop 10% globally. The leading podcast for founders, investors, and policymakers shaping the future of biotech, deep tech, and innovation.Follow the show to explore more conversations like this one — where science meets strategy and leadership builds the future.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
213
EP 169 - Why New Year’s Goals Fail by February - Even for Disciplined People
Most goals don’t fail because of laziness or lack of ambition.They fail quietly — buried under daily noise, competing priorities, and forgotten intentions.By March, even the most meaningful goals have slipped down the list… replaced by urgency, meetings, and excuses.In the last years, whenever I work with companies or people in my executive coaching a pattern showed up frequently.In private life: marathons abandoned, educations postponed, mountains left unclimbed. In business: bold visions diluted, priorities scattered, companies losing momentum — not because the goal was wrong, but because it was never protected.This Year in Review 2025 episode is my answer to that problem.After working with founders, executives, and teams throughout the year, one truth became unavoidable:Big goals don’t fail because people stop caring. They fail because they lose daily contact.So I stripped goal-setting down to what actually works.To make it memorable, I revisited the conversations of 2025 and selected six voices — from politics, investing, entrepreneurship, and professional sport — each illustrating one essential principle for achieving meaningful goals.No hype. No motivational slogans. Just a clear, calm framework you can apply immediately to your most important goal for 2026.🧭 What You’ll Learn in This Episode1️⃣ Why discipline and motivation are overrated — and what replaces them2️⃣ How goals quietly disappear without friction or resistance3️⃣ Why choosing one goal is the highest-leverage decision you can make 4️⃣ How to keep goals present without pressure or obsession 5️⃣ Why process builds identity — and outcomes don’t 6️⃣ What real commitment looks like when nobody is watching⏱️ Timestamps(00:00) Why New Year’s Resolutions Collapse — and What Actually Works(02:57) Karl Nehammer — “Sometimes there is no guidebook” (04:19) How Goals Quietly Disappear (07:56) Alex Dang — Focus, Selection, and Knowing When to Fold (11:45) Hack Away the Unessential — Choosing One Goal (14:05) Fabrizio Conicella — Skills Entrepreneurs Need in 2026 (17:54) Why You Must Review Goals Daily (19:43) Jason Foster — Setting Big Goals and Chipping Away (20:48) Process Over Outcome (22:48) Alasdair Milton — Doing the Work When Nobody Is Watching (26:05) Start Now — Before It Feels Comfortable (27:50) Vadim Fedotov — What Commitment Really Means (30:54) Before You Leave — Ed Sheeran’s Approach to Progress🎙️ About This EpisodeThis episode isn’t about setting more goals. It’s about protecting one goal that actually matters — whether you’re building the next NVIDIA, scaling a company, or working toward a personal milestone.If 2025 taught us anything, it’s this:Clarity beats intensity. Direction beats urgency. Process beats motivation.May 2026 be the year your most important goal doesn’t get lost.I’m glad you’re here.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
212
EP 168 - Alasdair Milton: The Innovation Inflection Point: Why 70% of Cures Never Reach Patients
Breakthrough science has never been stronger — yet patients still miss life-saving therapies.Despite decades of innovation, most precision medicines fail at the last mile of healthcare delivery.The problem isn’t discovery. It’s how science, capital, and systems are aligned — or not.Possessing elite science is no longer enough to win in the multi-trillion-dollar biopharma ecosystem.As innovation shifts from West to East and from treatment to prevention, leadership teams struggle to bridge scientific depth with incentives, execution, and real-world delivery. Capital follows speed and scale — not intention — and healthcare systems built decades ago are failing to keep up.In this episode, Alasdair Milton, Principal at KPMG, explains where innovation actually breaks — and what must change for cures to reach patients at scale. From diagnostics and data silos to capital allocation and prevention models, this conversation reframes the next decade of precision medicine.💡 What You’ll Learn in This Episode1️⃣ Why only a fraction of eligible patients receive precision therapies2️⃣ How delivery systems — not science — kill innovation outcomes3️⃣ Why prevention is the next major value shift in healthcare4️⃣ How capital allocation decisions quietly determine patient access5️⃣ What leaders must change now to compete in the next biopharma cycle👤 About Alasdair MiltonAlasdair Milton is a Principal at KPMG advising global biopharma leaders on strategy, transactions, and innovation models. With a PhD in cancer biology and two decades at the intersection of science and capital, he works with executives navigating precision medicine, prevention, and large-scale healthcare transformation.💬 Quotes That Reframe the Debate(01:00:20) “Great science only creates value when translated into clear commercial decisions.”(01:37:24) “Power has swung decisively to pharma, with biotechs now starved for capital and leverage.”(01:36:10) “Markets shift fast, but leverage always follows capital, data, and disciplined execution.”(02:26:30) “Life sciences must move from treating sickness to predicting risk and sustaining lifelong wellness.”(01:46:24) “China is catching up fast, and by the 2030s, truly innovative molecules may originate there.”🧭 Timestamps(00:04:04) Shifting from treating disease to preventing it(00:05:32) Turbulent markets, steady scientific progress(00:07:03) In-vivo CAR-T and the next leap in cellular medicine(00:11:00) From chronic disease management to functional cures(00:20:20) Bridging specialized science with corporate strategy(00:21:55) Translating lab precision into business language(00:22:07) Bridging scientific depth to business acumen(00:57:40) Turning complex science into decisive commercial implications(01:08:46) Why in-person collaboration still drives leadership and learning(01:11:48) Navigating the $200B biopharma patent cliff through M&A(01:17:25) Capital concentrates on de-risked teams with proven leadership(01:18:17) Interpreting the biotech market recovery and tailwinds(01:28:26) Long-term capital returns as pharma reclaims deal leverage(01:38:03) Navigating IRA impacts and macro headwinds(01:43:39) China’s rapid ascent in the global monoclonal pipeline(01:46:24) China accelerates the eastward shift in global innovation(02:07:31) Precision medicine redefines individualized healthcare outcomes(02:09:03) Standardized data transforms healthcare delivery(02:16:57) AI across the precision medicine continuum(02:26:30) From reactive treatment to proactive lifelong wellness Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
211
#167: Pattern Breakers — 7 Laws Behind Category-Defining Companies
Most founders obsess over ideas.Breakthrough companies obsess over inflections, conviction, and structure.This episode unpacks Pattern Breakers by Mike Maples Jr.—a book that quietly explains why most startups never break out… and why a small minority reshape entire categories.But this isn’t a book summary.It’s a thinking upgrade for founders, operators, board members, and investors navigating the most fragile phase of company building: Series A to IPO, where timing, conviction, and structure matter more than features or pitch decks.Across seven tightly structured lessons, this episode explores how pattern-breaking companies are built before the world is ready for them—and why success is rarely about genius ideas, and almost always about seeing the future early and designing for it deliberately.You’ll hear why:breakthroughs start with external inflections, not internal brainstormingwinning companies are non-consensus and right, long before they’re popularmovements outperform products when markets get noisyMVPs test interest, but prototypes test desperationproductive disagreeableness protects insight when pressure risescorporate success quietly creates biases that kill innovationand why structure—not culture—is the hidden lever behind breakthroughsEach lesson is grounded in real company examples, translated into today’s market reality, and finished with coaching questions you can use immediately—in leadership meetings, boardrooms, or investment decisions.Key TakeawaysInflections Beat Ideas Breakthrough timing comes from external change, not creativity.Non-Consensus Is the Signal If everyone agrees, upside is already gone.Movements Outrun Products Identity compounds longer than features.Test Desperation, Not Interest Scalability starts with craving, not curiosity.Protect Conviction Consensus feels safe. It rarely creates breakthroughs.Design for Breakthroughs Small, protected, fast teams outperform bureaucracy every time.Timestamps(00:00) Intro(02:58) The Big Idea Behind Pattern Breakers (05:19) Who Is Mike Maples — and Why His Perspective Matters (07:35) Lesson 1: Start With Inflections, Not Ideas (12:36) Lesson 2: Be Non-Consensus and Right (17:31) Lesson 3: Prototype the Future, Not the MVP (21:31) Lesson 4: Recruit, Lead, and Scale Through Movements (26:20) Lesson 5: Master Productive Disagreeableness (30:04) Lesson 6: Break the Corporate Biases That Kill Breakthroughs (35:00) Lesson 7: Structure for Breakthrough Execution (39:41) Key Takeaways — The Lenses and Habits That Matter (42:21) Personal Reflection & Critique Why ListenLearn how category-defining companies are built before markets openUpgrade how you evaluate startups, strategies, and leadership teamsReplace product thinking with inflection, conviction, and structureWalk away with questions that immediately sharpen decisionsFound this valuable?Like, share, and follow.Every signal helps grow the show—and brings you more thinking frameworks from people and companies who didn’t follow patterns… they broke them.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
210
SPARK20 – 156: Janos Pasztor | The Climate Diplomat Who Refuses to Give Up on Humanity
The world has grown quiet about climate change. Too quiet.We scroll past floods, fires, droughts… and move on with our day.As if the problem solved itself.As if we’ve earned the luxury to look away.Janos Pasztor (full episode) has spent 40 years inside the rooms where climate decisions are made — from serving as UN Assistant Secretary-General for Climate Change to advising presidents, prime ministers, and global institutions.And in this SPARK20 highlight episode, one truth stood out:We are not done with climate change.We are only entering its most consequential chapter.This is not a doom story.It is the story of a man who still believes humanity can choose a better future — if we’re willing to face the questions we’ve been avoiding.What You’ll Learn in 20 MinutesWhy global warming accelerates even as we reduce emissions (00:01:15) And why governments are still “not addressing the issue sufficiently.”Why adaptation alone cannot save us (00:01:54) And what the real limits of adaptation look like.Why Janos believes we may need to cool parts of the planet (00:02:32) And why no political leader wants to say it out loud.How climate diplomacy changed since the 1980s — and why it matters now (00:03:32) Including the rise of China in global negotiations.Why capitalism itself may need to evolve (00:08:05) And what this means for investors, innovation, and global stability.What geoengineering really is (and is not) (00:09:16) Forget the internet myths — this is the factual explanation.Why volcanic eruptions hold a clue to future climate solutions (00:12:04) Why SRM is scientifically feasible — and politically dangerous (00:17:11) The technology is simple. The governance is not.Why the biggest risk of SRM is not cost — but consent (00:17:44) And what happens when societies don’t get a say.What a unilateral climate intervention could trigger (00:20:33) A scenario every policymaker should hear.Why Janos still believes in a brighter future (00:21:07) A rare moment of optimism from someone who has seen every side of the crisis.Quotes to Carry With You📌 “Global temperatures continue to rise — and the world is not ready.” (00:01:15)📌 “We must consider whether the time has come to start cooling parts of the planet.” (00:02:32)📌 “Three degrees of warming is cuckoo land. You simply cannot adapt to that.” (00:18:23)📌 “Technology is not the issue. It’s cheap. The real question is: do societies want this?” (00:17:11)📌 “I wouldn’t be here if I didn’t believe we can still get this right.” (00:21:07)Why This Conversation MattersBecause climate change isn’t a chapter we finished.It’s the foundation on which every other chapter of the future will be written — our economies, our food systems, our borders, our investments, and the lives of our children.And while Elon Musk may one day take humans to Mars, no one alive today will move there.This planet is the one we must keep habitable.Janos Pasztor is a reminder that realism and hope are not opposites — they’re partners.👉 Listen now. Share it forward. Keep the conversation alive.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
209
EP 166 - Karl Nehammer: Why Europe Fails to Scale – And How the EIB Plans to Fix It
Europe leads the world in discovery — yet too often, its breakthroughs never become global companies.Billions in research funding turn into patents, not products.While others build empires from ideas, Europe risks becoming the world’s laboratory — brilliant, but broke.That’s the paradox at the heart of this conversation.In this episode, Karl Nehammer, Vice-President of the European Investment Bank (EIB) and former Chancellor of Austria, joins Christian Soschner live at BIO-Europe 2025 to discuss how Europe can turn its world-class science into world-class companies.He shares how leadership forged in crisis can rebuild confidence, competitiveness, and growth — and why every crisis hides an opportunity to start thinking differently.💡 What You’ll Learn in This Episode1️⃣ Why Europe’s innovation system struggles to turn discovery into scale2️⃣ How the EIB can bridge the gap between science, capital, and market impact3️⃣ Lessons from leading through COVID-19, the energy crisis, and diplomatic challenges4️⃣ Why changing culture and regulation is key to Europe’s competitiveness5️⃣ The mindset Europe needs to move from surviving to building💬 Quotes from Karl Nehammer(00:03:33) “Every crisis is also maybe a chance — you learn a lot, decide quickly, and think in totally new ways.”(00:07:00) “We have the knowledge now of what we must change — it’s a window of opportunity.”(00:20:03) “Empower yourself. Don’t wait for another person — you can do it yourself.”🧭 Timestamps(00:00:00) Opening – Why Europe Struggles to Scale(00:03:33) Karl Nehammer – Leadership Lessons from Crisis(00:06:21) Europe’s Innovation Challenge – Science vs. Commercialization(00:09:17) Life-Science Resilience – Lessons from COVID-19(00:12:52) A Realistic Vision for Europe’s Future(00:17:05) Inside the European Investment Bank – Building Bridges Between Capital and Innovation(00:18:59) Empowering Founders – Karl Nehammer’s Message to Europe’s Builders(00:20:14) Closing – Optimism, Collaboration, and Confidence🎙️ Beginner’s MindTop 10% globally. The leading podcast for founders, investors, and policymakers shaping the future of biotech, deep tech, and innovation.Follow the show to explore more conversations like this one — where science meets strategy and leadership builds the future.Send us Fan MailSupport the showJoin the Podcast Newsletter: Link
-
208
EP 165 – Jason Foster: 153 Rejections Later — What Every Founder Must Learn About Resilience
Most founders dream of raising millions. Few survive the 153 “no’s” it takes to get there.Behind every biotech breakthrough lies exhaustion — late-night calls, failed rounds, and investors who walk away at the finish line.What separates the ones who make it isn’t luck or timing — it’s resilience built into process.In this episode, Jason Foster, CEO of Ori Biotech, shares how he transformed relentless rejection into a billion-dollar trajectory. From rebuilding cell-therapy manufacturing to leading global teams through economic storms, Jason reveals how founders can systematize grit, master storytelling, and survive when everything seems to fall apart.You’ll learn how to navigate fundraising winters, why leadership begins with self-care, and how to build companies that endure long after the hype fades. If you’ve ever doubted your path as a builder, this conversation will remind you that resilience is not a trait — it’s a practice.💡 What You’ll Learn in This Episode1️⃣ The real reason most founders fail long before capital runs out2️⃣ How to turn rejection into momentum using process and habit3️⃣ Why storytelling is the most underrated skill in biotech leadership4️⃣ How resilience and self-care directly drive performance and valuation5️⃣ The mindset that separates enduring companies from short-term success👤 About Jason FosterJason Foster is the CEO of Ori Biotech, a leading innovator transforming cell and gene therapy manufacturing. With 20+ years in global health, he has raised over $140M, led companies through IPO-level growth, and serves as a mentor and investor to emerging founders in life sciences. His mission: make advanced therapies accessible to every patient, everywhere.💬 Quotes That Might Change How You Think(00:14:09) “There are cures for cancer today, but patients can’t reach them — access must change.” (00:37:22) “The science is extraordinary — but if we can’t make it at scale, it means nothing.” (01:22:17) “Purpose, not money, drives talent to transform lives through innovation.” (01:46:17) “Fundraising is a war of attrition — constant rejection tests your resilience more than your idea.” (02:02:16) “You only have to get up one more time than you’re knocked down.” 🧭 Timestamps to Explore(00:02:00) Embracing Hard Challenges — How Biotech Founders Build Resilience That Lasts(00:13:40) The Unacceptable Truth: Cures Exist, Yet Patients Still Can’t Access Them(00:26:23) Navigating Cultures — What European and American Biotech Leaders Can Learn From Each Other(00:32:52) Why Great Science Isn’t Enough Without Commercial Viability(00:39:19) Revolutionizing Cell Therapy Manufacturing — The Seven-Day Bottleneck Explained(00:50:11) Automation and Digitization — Unlocking Scalable Patient Access in Cell and Gene Therapy(01:09:30) Rethinking Capacity Utilization — Making Regional Biotech Manufacturing Centers Work(01:14:27) Mass Personalization — The Future Delivery Model for Advanced Therapies(01:23:00) Purpose-Driven Talent — The Secret to Retaining Top Biotech Performers(01:32:18) Fundraising as a War of Attrition — Building Vision Alignment With Investors(01:39:14) Building Investor Trust Before You Need It — A Founder’s Long Game(01:47:23) Resilience Transforms Rejection Into Triumph — Lessons From 153 Investor “No’s”🎙️ Beginner’s MindTop 10% globally. The leading podcast for founders, investors, and policymakers shaping the future of biotech and innovation.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
207
EP 164 - Kat Kozyrytska: AI in Pharma Is a Yesterday Problem – Why Ethical Frameworks Can’t Wait
Imagine waking up to find your company’s most valuable IP leaked—not by hackers, but by the very AI tools you trusted.This isn’t a distant scenario; it’s happening inside pharma and biotech right now.And the cost isn’t just financial—it’s patient lives, broken trust, and an industry on the edge of losing credibility. In this episode, Kat Kozyrytska shares how leaders can act before invisible risks become catastrophic. From her personal journey in post-Soviet Ukraine to building frameworks in global biotech, Kat reveals why “yesterday problems” with AI demand urgent attention today.You’ll learn how data privacy failures propagate quietly, why embedding organizational values into AI is essential, and how collaboration across companies can safeguard innovation and accelerate therapies. The future of biotech won’t be secured by hype or speed—but by trust, ethics, and the courage to act before it’s too late. 🎧 What You’ll Learn in This Episode 1️⃣ Why “yesterday problems” with AI in pharma are already costing billions 2️⃣ How data privacy failures silently erode trust, IP, and patient safety 3️⃣ The difference between collaboration and competition in biotech innovation 4️⃣ Why embedding organizational values into AI is no longer optional 5️⃣ The future of drug discovery, clinical trials, and manufacturing in an AI-first world 👤 About Kat Kozyrytska Kat Kozyrytska is the Founder of the Cell Therapy Manufacturability Program and a global thought leader at the intersection of biotech and AI. With roots in Ukraine and a career spanning MIT, Stanford, Thermo Fisher, Sartorius, and global biotech startups, she bridges technical depth with ethical foresight. 💬 Quotes That Might Change How You Think (00:14:50) "AI can amplify good or bad behaviors — the choice is ours." (00:38:14) "Discovering dark personalities is like learning Santa isn’t real — traumatic, but suddenly everything makes sense." (01:03:26) "AI speaks with absolute confidence, but confidence is not the same as truth." (01:20:22) "AI gives us a rare chance to embed ethics and values into innovation." (01:57:01) "If personalized therapies work better, we have an ethical duty to deliver them." 🧭 Timestamps to Explore (00:05:16) From Math to Medicine – Kat’s unexpected path from equations to biotech leadership (00:09:38) Inside a Nobel Lab – How neuroscience breakthroughs shaped her ethical lens (00:12:27) Shadow AI – Why biotech leaders can’t wait to govern hidden systems (00:23:03) Data Sharing Paradox – Collaboration vs confidentiality in pharma innovation (00:31:31) Neurobiology of Manipulation – How dark personalities exploit human trust (00:41:18) Hidden Privacy Risks – What your everyday data footprint really reveals (00:52:17) Soviet Control vs American Individualism – Lessons for AI governance today (00:57:30) The Danger of One Answer – Why converging on a single AI truth is risky (01:02:51) Confidence ≠ Expertise – Rethinking how we trust AI in science (01:18:16) Embedding Core Values – How leaders can align AI with human ethics (01:51:28) Breaking Down Silos – The future of collaborative drug discovery with AI (02:14:39) Biotech 2035 – Kat’s optimistic vision for an ethical AI future 🎙️ Beginner’s MindTop 10% globally. The leading podcast for VCs, operators, and anyone obsessed with building what comes next. Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
206
#163: The NVIDIA Way — 7 Scaling Lessons from Jensen Huang’s Playbook
Most founders obsess over products. Jensen Huang built a $3 trillion company by obsessing over inevitabilities. This episode unpacks The NVIDIA Way by Tae Kim—the definitive account of how NVIDIA went from near-death startup to the world’s most valuable chipmaker. More than a history, it’s a manual for founders and VCs navigating the messy, high-stakes stretch between Series A and IPO. But this isn’t just about NVIDIA. It’s about you—if you’re scaling in deep tech, where survival depends less on genius inventions and more on how you engineer resilience, culture, and urgency into your system. I walk you through 7 scaling lessons that matter now—from why pain is a founder’s greatest teacher to how vision and culture become moats no competitor can copy. Each principle is grounded in NVIDIA’s story, translated into today’s market reality, and wrapped with coaching prompts you can act on this week. Key Takeaways: Pain Builds Resilience: Intelligence helps, but scars compound faster.Reputation Is Currency: Your first product isn’t a chip or an app—it’s trust.Defy the Innovator’s Dilemma: Don’t chase quarters—build inevitabilities.Lead with Context: Replace bottlenecks with clarity and extreme ownership.Sell the Vision: Markets follow narratives, not features.Culture Outruns Capital: Execution habits compound longer than cash.Urgency Wins: Complacency kills more companies than competition.Timestamps: (00:00) Why This Episode Matters (02:18) The Big Idea of The NVIDIA Way by Tae Kim (04:36) Who is Tae Kim? (08:15) Lesson #1: Pain and Suffering Are the Recipe for Greatness (12:35) Lesson #2: Your Reputation Is Your Currency (17:05) Lesson #3: The Innovator’s Dilemma Will Come for You (21:45) Lesson #4: Lead With Context, Not Control (25:18) Lesson #5: Don’t Just Sell the Product—Sell the Vision (30:00) Lesson #6: Culture Outruns Capital—and the Competition (34:32) Lesson #7: Build Urgency Into the System (38:30) Key Takeaways—3x Reading + 25 Years in Public Markets, VC, and Scaling Deep Tech (41:24) Reflection Why Listen:Learn how NVIDIA survived near-death and built inevitabilities that defined AI.Get 7 leadership and culture principles designed for Series A–IPO scale-ups.See how to evaluate companies not by products, but by the systems that endure.Upgrade your founder or investor lens with actionable coaching questions.Found this valuable? Like, share, and follow. Every signal grows the show—and helps bring you more playbooks from the world’s most resilient companies. 🎙️ - Beginner's Mind. Top 10% global. #1 deep tech podcast. 200+ episodes. Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
205
Marc Penkala | Why Being Wrong is the Secret to Venture Success (SPARK20 – 139)
How do you succeed in a business where being wrong is the norm?Marc Penkala has lived both sides of the table: as an entrepreneur who built, sold, and failed with companies—and now as a venture capitalist running his own fund. What makes his story different is the radical honesty about what actually drives success in venture: failure, timing, and taking risks that look stupid at first.This Spark20 episode distills Marc’s hard-earned lessons into a 20-minute masterclass for founders, investors, and policymakers navigating uncertainty.What you’ll learnWhy timing, not brilliance, often decides who wins.Why failure is the ultimate credibility builder for investors.How European founders hold themselves back—and what mindset shift is overdue.Why down markets are the best time to build companies.How the “stupidest ideas” sometimes create the biggest outliers.Timestamps & Quotes📌 (00:00:38) Entrepreneur → VC “My route into venture capital felt like a paid executive MBA… I built, I sold, I bankrupted, and then I joined the so-called evil side to truly understand investors.”📌 (00:03:31) Failure as Fuel “Failure is the bigger success… many of my failures turned into the best things that ever happened.”📌 (00:05:32) Credibility Through Scars “If I had never built a company, how could I authentically tell a founder I can help them?”📌 (00:07:29) Wrong = Right in Venture “As a VC, you’re more often wrong than right. And strangely, the more you’re wrong, the higher your actual output.”📌 (00:10:38) When Tourists Arrive, Leave “The moment angels and LPs with no clue flood the market, you literally have to stop investing. That’s when the tourists arrive.”📌 (00:12:22) Outliers Make the Portfolio “One angel had ten bets—two of them gorillas and Tier. Didn’t matter what else he had—the outliers alone defined him.”📌 (00:13:02) Europe vs. US Mindset “US startups think in billions. European startups think in millions. That mentality shift is everything.”📌 (00:15:02) Stupid Ideas Win “If everyone agrees it’s a great deal, don’t do it. The best investments sound like the stupidest idea at first.”📌 (00:17:42) Why Down Markets Build Giants “In down markets, founders get humble, go back to fundamentals, and focus on capital efficiency. That’s why the best companies come from downturns.”This isn’t just a highlight reel—it’s a reminder that in venture capital and entrepreneurship, the rules are upside down. Being wrong isn’t a weakness—it’s proof you’re taking the swings that matter.👉 Listen now, and share it with someone who needs to think bigger.🎙️ With over 200 interviews, panels, and livestreams, Beginner’s Mind ranks in the Top 10% globally—and is recognized as the leading deep tech podcast forSend us Fan MailJoin Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
204
EP 162 - Alex Oppenheimer: The Secret Investors Use Before Writing the First Check
Here’s the harsh truth: If your business model can’t survive a spreadsheet, it won’t survive the market.Every year, ambitious founders pour months into product, pitch, and brand—yet the single biggest reason startups die isn’t funding, it’s flawed modeling.What are the four variables investors use to spot winners before anyone else?In this episode, investor and hands-on builder Alex Oppenheimer (Founder & GP at Verissimo Ventures, ex-Facebook IPO, ex-NEA, Monday.com advisor) reveals why most startup advice misses the point—and how the best founders reverse-engineer success long before a single euro is raised.🎧 Watch now to learn: 1️⃣ The business model simulation Alex uses to kill (or greenlight) a deal in under an hour 2️⃣ The one thing top VCs always ask founders—but almost nobody prepares for 3️⃣ Why a founder’s “calling” is more important than their credentials 4️⃣ How to avoid the European trap of ignoring leverage and failing to scale 5️⃣ The subtle mindset shift that separates bold investors from the herd—and how to apply it to your own company👤 About Alex Oppenheimer Stanford-trained engineer, ex-Morgan Stanley tech banker, NEA Series A investor, Monday.com operator, and now founder of Verissimo Ventures—a fund that bets on weird tech and next-gen software models in Israel, the US, and Europe.💬 Quotes That Might Change How You Think: (00:59:00) “If I don't build this, nobody else will—that’s the founder’s true calling.” (01:12:45) “How can you know what data to collect if you don’t know the model?” (01:22:36) “The real job of an investor is helping great founders not mess it up.”🧭 Timestamps to Explore: (00:04:00) Quitting Corporate Venture—The Decision That Changed Everything (00:11:50) What Business Modeling Is (and Isn’t) (00:18:30) Trusting the Founder Over the Deck (00:24:40) Venture Capital and the Power of Naivete (00:34:03) Inside the Facebook IPO Data Room (00:44:38) Lessons from Betting on Outliers (00:49:48) Leaving NEA to Build Israel’s Next Scaleups (01:02:32) From Frustration to Founding a Venture Fund (01:10:57) Why Business Modeling Remains a Blind Spot (01:14:09) Redefining Value Investing in Venture Capital (01:15:50) Decoding Value with Core Variables (01:22:36) Helping Founders Avoid Unnecessary Pitfalls Early 🔔 Like what you hear? Follow the show and share this episode with one builder, founder, or investor you respect. Every share helps us bring new industry leaders and sharper insights straight to you. Subscribe now—your next breakthrough could be one episode away.🎙️ Beginner’s Mind Top 10% globally. The leading podcast for VCs, operators, and anyone obsessed with building what comes next.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
203
EP 161 - Enis Hulli: VC Secrets Exposed: Why Only US-Based Startups Dominate (and How to Beat the Odds)
Why do Europe’s brightest founders still feel forced to leave for Silicon Valley—no matter how much money or talent we pour into the region? Every year, ambitious startups across Europe and CEE struggle to scale—not for lack of ideas, but because of invisible barriers that keep global success out of reach.Is it really just about capital—or is there a deeper mindset and playbook that only a handful of founders ever discover?In this episode, venture insider Enis Hulli (General Partner at e2vc, investor in 40+ startups, 3 unicorns, and builder of bridges from Istanbul to the Bay) pulls back the curtain on the real reasons US-based startups keep winning—and how founders from Turkey, Eastern Europe, and beyond can finally turn the tables.🎧 Watch now to learn: 1️⃣ The “power law” that decides which founders build generational companies—and why most never see it coming 2️⃣ Why relationships, not pitch decks, determine who actually gets funded—and how to break through if you don’t have the right connections 3️⃣ How emotional resilience and founder mindset shape the fate of entire regions—not just individuals 4️⃣ The little-known risks of playing the European “safe game”—and how to engineer luck for outsized results 5️⃣ Tactical lessons on team building, brand, and why your anti-portfolio (the deals you missed) might matter even more than your winners👤 About Enis Hulli Enis is General Partner at e2vc, a leading early-stage venture fund focused on scaling tech startups from Emerging Europe to global markets. With investments in 40+ companies (including three unicorns), he’s spent his career helping founders unlock the path from local player to world-class leader.💬 Quotes That Might Shift Your Thinking: (01:30:44) “I don’t think we’ll see founders choosing Europe over the US in our…” (01:34:37) “There are twenty different ways to kill a reputation on any side of the…” (01:38:31) “To avoid complacency, I surround myself with people who make me feel like I…”🧭 Timestamps to Explore: (00:16:58) How the Bay Area’s Talent Network Effect Became Unstoppable (00:20:48) Work-Life Balance vs. Blitzscaling—What It Really Takes to Go from Zero to One (00:25:43) Why Founders Trump Pitch Decks Every Time (00:30:38) The Perils of Planning for an Exit Too Soon (00:34:34) The Three Qualities Every VC Looks For—And Why Mindset Still Wins (00:40:30) How IPO Markets Shape (and Break) Venture Capital (00:43:52) Fundraising Mistakes That Kill FOMO and Crush Deals (01:12:58) Why Bay Area Mindset Still Outpaces Europe’s Best (01:30:44) The Real Reason Europe Loses Its Unicorns (01:34:37) Reputation, Relationships, and the Hidden Dangers of VC Control (01:38:31) How Top Investors Avoid Complacency and Stay Hungry🔔 Follow the show and leave a review. Every follow, like, and share brings new global voices, industry leaders, and sharpest insights straight to you.🎙️ Beginner’s Mind ranks in the Top 10% globally—and is recognized as the leading deep tech podcast for scientific entrepreneurship.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
202
EP 160 - Vadim Fedotov: Elevate Your Wellbeing: How Data-Driven Choices Create Peak Performance
Still trying to optimize your health with guesswork and generic advice?Most people settle for “one-size-fits-all” supplements and hope for the best-missing out on the breakthroughs that only real data and personalization can offer.In a world flooded with empty promises, few realize how quickly tailored, science-backed solutions can transform energy, focus, and longevity.Enter Vadim Fedotov—ex-pro athlete, CEO, and co-founder of Bioniq, the health tech company bringing truly personalized care to the world’s top leaders, innovators, and athletes.In this eye-opening conversation, Vadim reveals why your biology is as unique as your fingerprint—and why the future belongs to those who personalize, measure, and adapt.Discover the systems, mindsets, and science behind optimizing human potential—without wasting time, money, or hope on outdated approaches.🎧 Watch now to explore: 1️⃣ The fatal flaw in “one-size-fits-all” wellness—and how personalization is rewriting the rules 2️⃣ How AI, data, and regular feedback loops empower you to outpace your peers—at work, in health, and in life 3️⃣ Lessons from elite sports: why discipline, team dynamics, and feedback matter in business 4️⃣ The “feedback loop” secret that’s changing the supplement industry forever 5️⃣ Vadim’s vision for a future where your fridge, wearable, and AI coach work together to help you thrive👤 About Vadim Fedotov Vadim is the co-founder and CEO of Bioniq, former CEO at Groupon, and a former professional basketball player with the German National Team and Buffalo Bulls. Driven by his passion for health optimization, he’s building a global, interdisciplinary network of thought leaders to put cutting-edge, personalized care within everyone’s reach.💬 Quotes That Might Shift Your Thinking: (00:08:27) "Personalized health isn't a trend; it's the future of wellness."(00:15:54) "There is no single right diet, exercise, or routine—every body truly needs something different."(00:44:11) "Personalization in health is not a luxury anymore; it’s quickly becoming a necessity."(01:06:26) "You only fail when you give up—resilience defines success."(01:23:21) "Seventy percent of your health is determined by nutrition, not pharmaceuticals or medicine."🧭 Timestamps to Explore: (00:03:32) Why Visionary Leaders and Families Move to Dubai (00:08:27) Personalizing Health Revolution How Data-Driven Wellness Changes Everything (00:09:27) Health as the New Wealth Post-Covid Insights (00:15:52) Busting Health Myths There’s No One-Size-Fits-All (00:18:28) Data Over Opinion Navigating Health Complexity (00:21:03) Olympic Research Sparks Personalized Health Innovation (00:23:51) When Obvious Solutions Don’t Exist—The Birth of Bioniq (00:25:40) When a "Dumb Idea" Becomes a Massive Opportunity (00:31:01) Setting Personal Health Goals With AI and Data (00:34:40) Real-World Feedback Loops Cut Through Wellness Hype (00:40:07) Data-Driven Breakthroughs That Save Lives (00:44:11) Why Health Personalization Is Now a Necessity (00:54:31) Leadership, Discipline, and Lessons from Elite Sports (01:01:04) Finding Pride and Resilience Against All Odds (01:23:21) Redesigning Healthcare Starting With Nutrition🔔 Follow the show. Leave a review. 🎙️ Beginner’s Mind ranks in the Top 10% globally—and is recognized as the leading deep tech podcast for scientific entrepreneurship.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
201
Angeli Möller | Building the Future of Health with Precision, Vision, and Heart (SPARK20 – 142)
How do you lead at the cutting edge of health, data, and AI—while staying deeply human?Angeli Möller has led global data science teams across pharma giants, co-founded one of Europe’s most ambitious AI alliances, and now builds high-performance biotech strategies with precision. But what truly sets her apart isn’t just her technical fluency—it’s her clarity, courage, and care in how she builds teams, solves problems, and pushes the boundaries of innovation.In this episode, Angeli opens up about the quiet frustrations that fuel her mission, the invisible cost of ignoring innovation, and the principles that guide her client work today. Whether you’re an investor, founder, or policymaker, her journey will reshape how you think about leadership, AI, and what truly moves the needle in healthcare.Here’s what you’ll take away:Why most AI projects fail—and how to spot the ones that won’t.How to lead technical teams with vision, warmth, and accountability.Why proprietary data matters more than fancy algorithms.What real innovation feels like—and how to know when you’re missing it.At the center of it all: a calm, fiercely smart leader who sees through the noise and builds what matters.As she says: “Start with the real problem. If you don’t understand the problem, AI won’t help you.”Timestamps & Topics📌 (01:08) Missed AI Integration Costs – “It’s faster, more effective, cheaper—but it’s not part of the core business yet.”📌 (03:57) AI vs. Real-World Drug Impact – “The question isn’t: does it use AI? It’s: does the medicine work?”📌 (04:48) Post-Hype AI Fallout in Pharma – “Fraud led to disillusionment. And investors paid the price.”📌 (06:39) Corporate Blind Spots in Innovation – “It’s a danger in business to think there’s nothing to learn from others.”📌 (09:40) Building a European AI Alliance – “At first, pharma didn’t take us seriously. That changed with the data.”📌 (11:02) Data Ethics and Regulatory Risk – “You can massively hurt your business through accidental bias.”📌 (13:19) Data Access for Rare Diseases – “The only solution is to make that data safely available.”📌 (15:22) Leadership Shift: From Bayer to Startup – “It felt too obvious. I needed something riskier, more meaningful.”📌 (21:23) Three Core Leadership Traits – “Vision. Technical understanding. And knowing when to bring in others.”📌 (22:27) Frictionless Health Tech Adoption – “It’s inevitable. The economics—and behavior nudges—are already shaping it.”This episode offers more than insight—it’s a playbook for building what’s next in health, tech, and leadership.👉 Listen now, and share it with someone ready to shape the future.🎙️ With over 200 interviews, panels, and livestreams, Beginner’s Mind ranks in the Top 10% globally—and is recognized as the leading deep tech podcast for biotech, AI, and scientific innovation. Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
200
#159: No Rules Rules — 7 Culture Principles That Made Netflix Unstoppable
Most founders add layers to gain control. Reed Hastings built an empire by removing them. This episode unpacks No Rules Rules—the leadership playbook behind Netflix’s rise from a DVD mail service to a global entertainment powerhouse. Co-authored by founder Reed Hastings and INSEAD professor Erin Meyer, the book reveals how to scale not through policy, but through trust, talent density, and extreme transparency. But this isn’t just about Netflix. It’s about you—if you’re building or investing in companies between Series A and IPO, where culture either compounds performance or quietly kills it. I walk you through 7 operational principles that deep-tech teams can apply now—lessons forged in crisis, growth, and reinvention. You’ll learn how to sunshine mistakes, pay like a pirate, and lead without becoming a bottleneck. Each principle is translated into coaching prompts, ready to implement this week. Key Takeaways: Culture Outruns Capital: Don’t optimize the engine—reinvent the vehicle.Pro Team > Family: Loyalty is earned through excellence, not tenure.Candor Drives Speed: Build feedback loops that fuel progress.Pay Top of Market: Buy peace of mind. Unlock creative flow.Bet Boldly: Seek dissent. Test. Learn. Repeat.Context Beats Control: Share the why. Let them own the how.Transparency = Trust: Open up, even when it’s uncomfortable.Timestamps: (00:00) Intro – Why Netflix Scaled Faster by Removing Rules, Not Adding Them (04:30) Who Is Reed Hastings? – From Math Teacher to Global Disruptor (09:13) Book Snapshot – What Makes No Rules Rules a Real Operating System (11:35) Lesson 1: Culture Outruns Capital – How Netflix Survived 4 Disruptions, Blockbuster Didn’t Survive One (17:25) Lesson 2: Build a Pro Team, Not a Family – Talent Density Over Loyalty (22:48) Lesson 3: Radical Candor = Speed – The Feedback Model That Fuels Innovation (27:34) Lesson 4: Pay Like a Pirate – Why Netflix Pays Top of Market—No Games, Just Outcomes (32:20) Lesson 5: Bet Bold, Fail Proudly – The 4-Step Innovation Cycle That Keeps Netflix Ahead (39:12) Lesson 6: Lead with Context, Not Control – Scaling Leadership Without Becoming a Bottleneck (43:28) Lesson 7: Transparency Builds Velocity – How Truth-Telling Became Netflix’s Superpower (48:15) 7 Key Takeaways – The Culture Playbook Every Growth-Stage Founder Needs (50:15) Personal Reflection – What I Questioned, What I’ll Steal, What Gave Me Pause (52:00) Call to Action + What’s Next – Support the Show + Tease of the Next Episode Why Listen: Learn how Netflix scaled without micromanagementGet 7 principles that push your org design, talent strategy, and leadership edgeDiscover where you're still playing defense—when your culture should be your offenseUpgrade your leadership thinking with real examples and immediate applicationsFound this useful? Like, share, and follow. Every signal grows the show—and brings in more elite guests ready to share the truths behind high-growth success. 🎙️ - Beginner's Mind. Top 10% global. #1 deep tech podcast. 200+ episodes. Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
199
EP 158 - Rafael Rosengarten: Why 90% of Cancer Drugs Fail — and the Radical AI Fix You’ve Never Heard Of
Most cancer drugs fail. Not because the science is wrong—because we’re solving the wrong problems.The cost? Over $2 billion per failure. And for the patient waiting on a miracle—there’s no second chance.Behind the headlines of “precision medicine,” there’s a deeper story nobody’s telling. Until now. 🎯 Enter Rafael Rosengarten, the scientist-turned-founder who’s rewriting the rules of drug development.In this gripping conversation, we unpack how RNA, AI, and deep empathy could finally close the loop between biology, data, and the patient in the room. 🎧 Watch now to explore: 1️⃣ Why drug failure isn’t a tech problem—it’s a strategy problem 2️⃣ How “information companions” will guide every medicine to the right patient 3️⃣ What pharma keeps getting wrong about biomarkers—and how to fix it 4️⃣ The untold story behind turning down a chef’s job on a Mediterranean yacht 5️⃣ The real reason Genialis may one day go out of business (and why Rafael hopes it does) 👤 About Rafael Rosengarten Rafael is CEO and co-founder of Genialis, the RNA biomarker company reshaping precision oncology. From academic labs to Michelin-star kitchens, his journey is anything but linear—but his mission is clear: make medicine make sense. With partners across pharma, diagnostics, and AI, Genialis is creating a world where every patient gets the treatment they actually need. 💬 Quotes That Might Shift Your Thinking: (00:58:37) “Our AI biomarkers de-risk clinical trials, slashing costs and saving lives.” (01:54:46) “Every drug will have an information companion guiding it to the right patient.” (01:14:32) “AI should free humans for empathy and creativity, not replace them.” (00:14:13) “We now have the tools to treat every cancer as unique to each patient.” (01:31:38) “Stop selling technology; sell solutions to real problems.” 🧭 Timestamps to Explore: (00:03:52) Inside the World’s Largest Medical Center (00:10:30) How AI Is Rewiring Precision Medicine (00:13:51) Why Precision Medicine Is Scaling Now (00:17:34) Startups Must Solve Market Needs First (00:23:53) Culture First, Then Business: Startup Blueprint (00:27:57) Cancer Isn’t One Disease—It’s Thousands (00:31:44) Predicting Drug Success with AI Biology (00:36:40) Reimagining Biomarkers Using RNA and AI (00:47:45) Why Early Detection Still Saves Lives (00:57:30) Why Most Cancer Drugs Still Fail (00:58:37) AI Biomarkers That De-Risk Clinical Trials (01:09:42) Rethinking Dosage with Predictive Algorithms (01:13:33) Why Human Intuition Still Matters in Science (01:36:41) The Crystal Ball Question Pharma Can’t Ignore (01:50:19) The moment where time disappears—and the real future begins. (01:53:39) Every Drug Will Have an AI Companion 🔔 Let’s Rebuild Trust in Medicine—Together If this episode sparked a new thought—or just gave you pause—don’t let it end here.Subscribe. Share it with someone who still believes medicine can be both scientific and deeply human.Every action brings in minds like Rafael’s… and gets us one step closer to treatments that truly heal. 🎧 Watch now—and discover how medicine gets smarter, safer, and more personal. Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
198
EP 157 - Fabrizio Conicella: Why Europe Keeps Losing the Next Breakthroughs in Medicine
Europe has the science. The talent. The breakthroughs.But when an idea feels too uncertain, our systems shut it down before it has a chance to breathe.And with every safe bet… we quietly lose the next cure, the next Car-T, the next AI that could change everything. 🚨 Risk-aversion, fragmentation, and bureaucracy are draining Europe’s innovation power—and nobody dares to name it out loud.But Fabrizio Conicella, VP of Open Innovation at Chiesi Group, isn’t holding back. 💡 In this deep, urgent conversation, Fabrizio shares how Europe can build the ecosystems we need to turn bold ideas into real-world impact—without compromising ethics, patients, or long-term value. 🎧 Watch now to explore: 1️⃣ Why uncertainty, not risk, is the true frontier of innovation 2️⃣ The hidden reasons startups leave Europe—and how to keep them 3️⃣ How Chiesi’s “The Impulse” model flips corporate R&D on its head 4️⃣ What every policymaker, CEO, and scientist must change before it’s too late 5️⃣ A bold new playbook for turning visionary science into trusted medicine 👤 About Fabrizio Conicella: As one of Europe’s leading voices in health innovation, Fabrizio is pioneering how pharma collaborates across startups, data, and ethics. His mission: create environments where the best ideas don’t get shut down—they get built. 💬 Quotes That Might Just Change Your Thinking: (01:58:01) "Be bold enough to dream, but pragmatic enough to make it real." (01:07:22) "Science is essential, but turning it into a product requires a different kind of wisdom." (01:04:35) "Visionary entrepreneurs see the future and change the game." (00:16:51) "Innovation today is no longer a race for ownership, but a journey of collaboration." (00:47:55) "If the idea is truly bold, no pharma company can replicate it without you." ⏱️ Timestamps: (03:00) Europe’s Innovation Crisis: A Wake-Up Call (08:19) Chiesi’s Bold B Corp Strategy (16:26) Building Healthcare Innovation Ecosystems (22:09) Predictive Medicine and Patient Data (29:49) Pharma vs. Startup Ecosystems Today (34:38) Why R&D Must Go External (35:06) The End of Buy-and-Wait Pharma (41:42) Ethics First: Pharma’s New Mandate (44:06) Respecting Founders, Not Just IP (47:23) Debunking the 'Pharma Steals Ideas' Myth (54:10) Why Pharma Moves Slowly—but Must Adapt (59:25) Market Acumen: Startups’ Missing Ingredient (01:04:35) What Makes a Visionary Entrepreneur (01:29:22) Embracing Failure to Spark Innovation (01:46:01) Europe’s Risk Culture is Holding Us Back 🔔 Help Us Grow the Future of Thoughtful Innovation If this conversation sparked something in you—an insight, a question, a sense of urgency—help us keep it alive. Subscribe. Leave a comment. Share it with someone who still believes bold ideas deserve a fighting chance. Every action brings in deeper minds, bigger questions, and the kind of leadership our systems so desperately need. Book mention: The Venture Mindset🎧 Watch now—and join the movement to rebuild Europe’s innovation edge. Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
197
EP 156 - Janos Pasztor: The Most Controversial Fix for Climate Change
What if the only way to save the planet... is to cool it? Not figuratively—literally. Because the heatwaves, floods, and fires you’ve seen so far? They’re just the beginning.🌍 Emissions keep rising. Global cooperation is slowing. And the window to act is closing fast. Now, world leaders are quietly weighing a radical idea: Should we artificially cool Earth before it’s too late?💥 In this explosive episode, we dive into the most controversial climate strategy on the table today: solar radiation modification.But who decides how much cooling is “enough”? What happens if we act too late—or worse, too soon?📌 In this episode, Janos Pasztor—former UN Assistant Secretary-General for Climate Change and climate advisor to Ban Ki-moon—breaks his silence on the plans world leaders are only now beginning to confront.🎧 Watch now to uncover: 1️⃣ Why geoengineering may soon become a global necessity—not a fringe idea.2️⃣ What governments aren’t telling you about unilateral climate interventions. 3️⃣ The ethical, political, and scientific minefield behind planetary cooling. 4️⃣ Why some scientists say this tech could save millions—and others call it madness. 5️⃣ What it will take to govern Earth’s thermostat before someone does it alone.👤 About Janos Pasztor: With nearly 50 years of experience in climate policy, diplomacy, and governance, Pasztor has shaped global climate strategy from inside the UN and beyond. From the 1992 Earth Summit to the corridors of the UN Security Council, he’s been advising heads of state on how to confront the world’s most complex crisis—and now, he’s sharing what’s coming next.💡 Quotes to Challenge Your Thinking: (00:08:41) “We must ask: is it time to start cooling parts of the planet?”(01:21:07) “Stratospheric aerosol injection could cool the planet—yet we barely understand its consequences.”(01:11:03) “The real question is whether capitalism can evolve beyond its dependence on resource extraction.”(02:24:41) “Three degrees of warming is cuckoo land—it’s beyond what humanity can realistically adapt to.”(02:47:03) “Climate policy isn't just climate—it’s about everything we do as a society.”⏱️ Timestamps: (00:04:12) Urgent Climate Crisis: Rising Emissions Explained (00:10:15) Inconvenient Truth 2.0: What We Missed (00:18:32) China’s Green Tech Revolution Unpacked (00:26:20) Can Climate Forums Deliver Real Action? (00:32:50) Designing Just, Achievable Climate Goals Globally (00:40:06) How Growth Triggers Today’s Polycrisis (00:45:08) Rethinking Economies for Sustainable Living (00:53:00) Why We Need Mixed Energy Strategies (01:17:24) Geoengineering vs Terraforming: Climate Futures Debate (01:26:20) Who Funds Carbon Removal Technologies? (01:37:06) Why We May Need to Cool Earth (01:40:41) Warming Beyond 3°C: What’s at Risk (01:48:02) How Fossil Fuels Hide True Heat (02:08:00) The Hidden Risks of Cheap Climate Fixes (02:24:41) 3 Degrees Warming: Scientifically Unmanageable? 🔔 Help Us Grow If this conversation gave you insight, urgency, or a new perspective—help us keep it going. Subscribe. Leave a comment. Share it with someone who cares. Every single action helps us invite world-class thinkers, spark deeper debates, and bring you the conversations that actually matter.🎧 Watch now—and be part of the climate conversation no one dares to start.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
196
#155: Ray Dalio’s Playbook — 7 Principles for Building Scalable, Resilient Companies
What if your business ran like a well-designed machine—one that could evolve, self-correct, and outperform your competition over decades?In this episode, I unpack Principles by Ray Dalio, the billionaire investor and founder of Bridgewater Associates, the world’s largest hedge fund. It’s not a traditional business book—it’s a blueprint for decision-making, culture design, and long-term scaling, rooted in clarity, transparency, and radical self-honesty.This episode is built for venture capitalists, executives, and operators leading at scale—those who are no longer improvising but building enduring systems.You’ll hear the 7 most actionable principles Dalio used to scale Bridgewater, reimagined for anyone building the future—from biotech to AI, from global funds to market-leading enterprises.We cover how to engineer feedback cultures, design for evolution, and drive decisions that compound over time. And we tackle the big question: Can you be both a high-performance machine and a human-centered leader?Key Takeaways:Think Like a Machine: Build systems that run without your constant input.Get the People Right: Talent isn’t enough—character and growth capacity matter most.Radical Transparency: Trust is built by saying the hard things early and often.Idea Meritocracy: Don’t default to consensus. Weight decisions by experience.Shaper Thinking: Zoom out to vision, zoom in to execution—and toggle constantly.Diagnose the Root Cause: Don’t waste time solving symptoms.Open-Mindedness as Strategy: Challenge your thinking before reality does.Timestamps:(00:00) Intro: The Principles(02:15) Why This Book Matters If You’re Building or Investing in the Future(04:14) Who Is Ray Dalio?(06:21) The Snapshot: What Principles Is Really About (10:05) Build Your Company Like a Machine, Not a Hero’s Journey (15:29) Get the People Right (20:40) Radical Truth & Transparency Are Force Multipliers (26:08) Build an Idea Meritocracy (32:26) Shapers Win—They Dream Big, Think Clear, Execute Ruthlessly (37:37) Diagnose Root Causes, Not Symptoms (44:02) Be Radically Open-Minded (50:12) Key Takeaways & Personal ReflectionWhy Listen:Learn how billion-dollar systems are designed and scaledIdentify blind spots in your leadership, org design, or investment thesesEquip yourself with 7 operating principles you can implement this quarterReframe your relationship to truth, conflict, and growthDecide whether to build a machine—or remain the operatorIf these ideas resonate, I strongly recommend reading Principles in full. Or better yet—share this episode with someone you think is ready to level up how they lead and build.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
195
Suzanne Heywood | From Shipwreck to Boardroom Leadership (SPARK20 - 133)
What does it take to turn extreme adversity into extraordinary leadership? Suzanne Heywood’s life reads like a novel—shipwrecked at seven, isolated at sea for a decade, forging her father’s signature to survive, and ultimately earning a place at Oxford through sheer determination. Today, she’s a top executive and investor, steering multi-billion-dollar companies with resilience, clarity, and innovation.In this episode, Suzanne shares the defining moments that shaped her, the mindset that helped her thrive in crisis, and the leadership lessons she applies in business today. Whether you’re an investor, entrepreneur, or leader, this conversation will leave you inspired and armed with valuable insights:How to stay calm under extreme pressure and make clear decisions.Why resilience isn’t about being tough—but about perspective.How diversity fuels innovation and why biases hold companies back.The ‘Critical Friend’ approach to leadership and board dynamics.At the heart of it all, Suzanne’s journey is a testament to perseverance and purpose. As she says:"You’ll learn things from adversity that people with an easier life never will."Timestamps & Topics📌 (01:00) Overcoming Extreme Adversity – A childhood lost at sea, a future built from nothing. 📌 (03:43) Knowing Which Mountains Are Worth Climbing – How to distinguish real challenges from distractions. 📌 (06:05) Resilience Under Pressure – From shipwreck to boardroom calm. 📌 (07:51) The Dangers of Bias in Innovation – Why lack of diversity kills progress. 📌 (09:39) Creating Sustainable Innovation – What great leaders prioritize for long-term success. 📌 (13:48) The ‘Critical Friend’ in Leadership – Balancing support with hard truths. 📌 (16:43) Metallica Meets Electric Trucks – A masterclass in creative partnerships. 📌 (18:29) Education as the Ultimate Investment – How learning transformed her life.Powerful Quotes💡 (03:43) "I picked kiwifruit… earned enough for a one-way ticket—Oxford changed my life." 💡 (06:58) "Nobody's life is in danger—we will get this sorted out." 💡 (20:39) "You’ll learn things from adversity that people with an easier life never will."This episode is more than an inspiring story—it’s a blueprint for navigating uncertainty, making tough decisions, and leading with conviction.👉 Listen now, take notes, and if this sparks something in you, share it with someone who needs to hear it!Send us Fan MailJoin Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
194
EP 154 - Kristina Levan: Why Life-Saving Therapies Aren’t Reaching Patients—And How to Fix It
ATMPs, gene therapies, and cancer breakthroughs are here—but outdated regulations, high costs, and logistical bottlenecks are blocking access. What needs to change for hospitals to deliver these cures to patients who need them most?💡 Here’s the harsh reality:Patients are waiting, but hospitals aren’t ready.The science exists, but regulations haven’t caught up.The treatments work, but they’re too expensive to scale.So what’s the solution? And who’s taking action?📌 In this episode, Kristina Levan—ATMP innovation leader and biotech strategist—breaks down the challenges and opportunities shaping the future of advanced therapies.🎧 Watch now to learn: 1️⃣ How gene therapy is curing blindness—and why it almost didn’t happen. 2️⃣ The biggest bottleneck preventing hospitals from offering life-saving treatments. 3️⃣ How AI and automation could unlock personalized medicine for everyone. 4️⃣ The real reason ATMPs are so expensive—and what must change. 5️⃣ Why healthcare leaders, policymakers, and investors must rethink how we manufacture cures.👤 About Kristina Levan: Kristina Levan has spent years at the cutting edge of cancer research, clinical trials, and ATMP development. She’s helped shape Sweden’s national ATMP strategy, connecting industry, healthcare, and academia to push these breakthroughs forward. Now, she’s tackling the next big challenge—getting these treatments to patients faster.💡 Quotes to Challenge Your Thinking: (00:12:05) "ATMPs don’t just treat symptoms—they have the power to cure diseases." (00:23:36) "Gene therapy is giving children a future—restoring sight and transforming their lives forever." (01:27:52) "Imagine a future where hospitals create customized gene therapies on-site for every patient." (01:43:13) "ATMPs could transform lives by treating the untreatable." (01:45:42) "If we can cure early, we don’t just save lives—we reshape them."Timestamps: (00:05:32) How ATMPs Will Reshape Global Healthcare (00:13:54) CAR-T Therapy: The Next Cancer Treatment Revolution (00:23:36) Gene Therapy Restores Sight—The Future of Medicine? (00:28:33) AI-Powered Therapies: Can Hospitals Manufacture Cures? (00:37:55) Why Cutting-Edge ATMPs Struggle to Reach Patients (00:53:36) Personalized Medicine & Real-Time Health Monitoring (01:09:02) From Research to Reality: Scaling ATMP Treatments (01:12:54) The True Cost of ATMPs—Can We Afford Innovation? (01:27:15) Cell Therapy Manufacturing: The Next Big Disruption (01:33:03) AI & Automation in Healthcare: What’s Next?🔔 Help Us GrowIf this episode gave you insight, inspiration, or a new perspective—here’s how you can help:📢 Hit SUBSCRIBE, like, and leave a comment. It’s a small action, but it has a huge ripple effect. Every engagement helps us bring in bigger guests, deeper insights, and more industry-changing conversations.Right now, we’re in the global top 10%—let’s push for the top 1% together.🎧 Watch now and be part of the conversation shaping the future of medicine. 🚀Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
193
EP 153 - Christopher Uhde: The Biotech IPO Boom is Over. Now What?
In 2021, biotech IPOs were soaring. Valuations hit record highs. Investors were throwing money at anything that moved.Then… the market crashed. Funding dried up. Growth stalled. Biotech founders and investors were left scrambling.So what really happened? And more importantly—how do you navigate what’s next?📌 In this episode, Christopher Uhde—Senior Pharma & Biotech Equity Analyst at SEB—breaks down the brutal realities of biotech IPOs, investor sentiment, and the high-stakes game of survival in a post-boom world.🎧 Watch now to learn:1️⃣ Why valuations aren’t about science—but about demand. 2️⃣ The biggest mistake biotech founders make after going public. 3️⃣ How to raise capital before you actually need it. 4️⃣ The European biotech advantage—and how to leverage it. 5️⃣ How to attract the right investors and avoid the wrong ones.👤 About Christopher Uhde:Christopher Uhde is a Senior Pharma & Biotech Equity Analyst at SEB, one of Europe’s leading financial institutions. With a PhD in neurodevelopmental systems biology and postdoctoral research in drug discovery, he’s spent years studying the biotech market—from billion-dollar giants to early-stage startups—analyzing their success, failures, and what separates winners from the rest.💡 Quotes to Challenge Your Thinking: 📌 (00:16:29) "Valuation isn’t about science; it’s about demand and the right investors." 📌 (00:49:17) "The power of the right team in biotech can’t be overstated." 📌 (01:13:08) "European startups struggle not from lack of innovation, but from a lack of ownership mindset." 📌 (01:38:39) "The long-term equity story isn’t just about share price—it’s about trust and vision." 📌 (01:50:44) "Biotech isn’t just about breakthrough science—it’s about strategy, trust, and long-term vision."⏰ Timestamps: (00:09:48) IPO Market Realities and Investor Sentiment (00:17:59) Why European biotech should think beyond US listings (00:25:15) The hidden challenges of taking a company public (00:28:45) Preparing for IPO Compliance (00:37:11) Public company leadership demands strategic communication (00:49:17) The power of the right team in biotech (00:52:48) Planning for success in biotech acquisitions (01:13:08) Incentivizing Innovation in Europe (01:23:33) Nordic IPO culture shaping biotech success (01:36:16) Realistic Communication in Biotech (01:50:44) Europe’s Biotech Global Edge🔔 Help Us GrowIf this episode gave you insight, inspiration, or a new perspective—here’s how you can help:📢 Hit SUBSCRIBE, like, and leave a comment. It’s a small action, but it makes a huge difference. Every engagement helps us bring in more top-tier guests, deeper insights, and the conversations that keep you ahead.Right now, we’re in the global top 10%—let’s push for the top 1% together.🎧 Watch now and make sure your biotech strategy is built to last. 🚀Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
192
EP 152 - Alex Dang: Billion-Dollar Bets: Why VC’s Best Decisions Go Against the Crowd
🚀 Most investors chase consensus. The best ones? They bet against it.If everyone agrees on an investment, it’s probably not bold enough. That’s why the greatest venture capitalists don’t just follow trends—they seek out the hidden outliers that redefine industries. But how do they spot the next Amazon, Google, or Tesla before anyone else? And why do so many leaders play it safe and miss out?📌 In this episode, Alex Dang—former Amazon and McKinsey leader—breaks down how elite investors think, how to cultivate the venture mindset, and why risk isn’t the enemy—short-term thinking is.🎧 Watch now to learn how to think like the world’s top investors.🎙️ What’s in the Episode:1️⃣ Conviction Over Consensus – Why the best decisions often go against the crowd.2️⃣ The VC Playbook – How top investors filter out noise and double down on outliers.3️⃣ Risk vs. Regret – The hidden cost of playing it safe.4️⃣ The ‘Day One’ Mentality – How Amazon avoids stagnation and bureaucracy.5️⃣ From Poker to Investing – The mindset shift that separates amateurs from professionals.👤 About Alex Dang:Alex Dang has lived the venture mindset firsthand—at Amazon, where he built new businesses; at AWS, where he launched cutting-edge AI solutions; and at McKinsey, where he helped Fortune 500 leaders scale transformative innovations. A Stanford GSB graduate, he’s spent nearly two decades guiding decision-makers through high-risk, high-reward environments.💡 Quotes to Challenge Your Thinking:📌 (01:21:31) "Conviction beats consensus. If everyone agrees, the idea isn’t bold enough."📌 (01:49:18) "VCs don’t fear losing money. They fear missing the next Google."📌 (00:31:08) "Home runs matter, strikeouts do not in the venture capital game."📌 (00:58:46) "In business, like poker, fold early or double down—there’s no in-between."📌 (00:47:00) "The moment you abandon a Day One mentality, bureaucracy wins."⏰ Timestamps:(00:04:58) AI's Next Big Disruption(00:20:08) Predictability vs. Innovation in Business(00:30:45) Venture Capital’s Risk Culture Explained(00:38:00) How Amazon Built a Venture Mindset(00:46:34) Day One vs. Day Two Thinking(00:53:22) Writing for High-Stakes Decision Makers(00:57:51) Poker Mindset in Venture Investing(01:11:07) Why Failure Leads to Billion-Dollar Wins(01:21:31) Conviction vs. Consensus in Investing(01:26:46) Avoiding the Crowd, Finding Outliers(01:32:47) Playing the Long Game in Venture(01:54:59) Optimism in Innovation’s Unpredictable Future 🔔 Help Us GrowIf this episode challenged your thinking, hit follow, like, and share. The bigger the show gets, the bigger the guests we can bring you—so you get even more game-changing insights.🎧 Watch now and start making billion-dollar bets like the world’s best investors. 🚀Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
191
#151: Mastering Uncertainty – 7 Venture Secrets to Thriving in Chaos
What if your greatest asset in business was how you think under pressure?In this episode, I dive into The Venture Mindset by Alex Dang and Ilya Strebulaev, unpacking seven transformative lessons drawn from the world of venture capital and deep-tech entrepreneurship. These principles aren’t just for investors—they’re a roadmap for anyone navigating uncertainty, from startup founders to corporate innovators.Alex Dang, a veteran innovator, and Ilya Strebulaev, a leading academic in venture capital, combine decades of hands-on experience and rigorous research. Together, they reveal how to embrace risk, think strategically, and build ventures that thrive in chaotic environments.As an entrepreneur and investor, I’ve found these lessons invaluable. This episode explores how to prepare your mind for contrarian thinking, align incentives for growth, and make bold decisions when it matters most. Whether you’re building groundbreaking technology or adapting to a disruptive market, these insights will reshape how you approach challenges.Key Takeaways:This episode covers seven critical lessons, including:1️⃣ Home Runs Matter, Strikeouts Don’t: Embrace failure as a stepping stone to transformative success.2️⃣ Prepare Your Mind for Contrarian Thinking: Spot opportunities others miss and thrive in uncertainty.3️⃣ Bet on the Jockey, Not Just the Horse: Prioritize resilient founders over flashy ideas.4️⃣ Double Down or Quit: Make disciplined decisions to invest or cut losses.5️⃣ Get Outside the Four Walls: Source ideas from diverse networks and unexpected places.6️⃣ Make the Pie Bigger: Align incentives to foster collaboration and shared success.7️⃣ Great Things Take Time: Cultivate patience and a long-term vision to achieve exponential impact.While this episode highlights actionable takeaways, The Venture Mindset is packed with even more insights and strategies for anyone looking to excel in unpredictable environments.Timestamps:(00:00) - Introduction: Why This Episode Matters(01:20) - The Book’s Relevance for Entrepreneurs and Innovators(02:02) - Author Spotlight: Alex Dang and Ilya Strebulaev(04:15) - Book Overview: A Roadmap for Thriving in Uncertainty(06:56) - Key Takeaway 1: Home Runs Matter, Strikeouts Don’t(12:43) - Key Takeaway 2: Prepare Your Mind for Contrarian Thinking(19:07) - Key Takeaway 3: Bet on the Jockey, Not Just the Horse(24:00) - Key Takeaway 4: Double Down or Quit(29:22) - Key Takeaway 5: Get Outside the Four Walls(34:00) - Key Takeaway 6: Make the Pie Bigger(38:53) - Key Takeaway 7: Great Things Take Time(43:55) - Closing Reflections and Final InsightsWhy Listen:Embrace Bold Thinking: Learn how to thrive in uncertainty with strategies from venture capitalists and entrepreneurs.Master Decision-Making: Equip yourself with tools to adapt and act decisively in chaotic environments.Drive Innovation and Growth: Gain insights into fostering collaboration, resilience, and long-term value creation.Practical Application: Reflect on actionable coaching questions tailored to your journey.If these lessons resonate, I encourage you to explore The Venture Mindset in full. It’s more than a book—it’s your guide to navigating uncharted waters and building a future-proof path to success.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
190
Dan Bowyer: Rethinking Venture Capital with Superseed VC (SPARK 20 – 125)
What does it take to redefine venture capital while empowering founders to disrupt industries and drive meaningful change? Meet Dan Bowyer, a bold investor from Superseed VC reshaping the game with a no-nonsense approach and a passion for impactful innovation.In this episode, Dan shares his journey from entrepreneur to VC and dives deep into what’s wrong with traditional venture capital. He reveals the personality traits that define world-changing founders, the importance of customer obsession, and the stark realities of boardroom dynamics. Dan’s candid insights and thought-provoking lessons are as entertaining as they are eye-opening.Whether you’re an aspiring founder, an experienced investor, or someone intrigued by the startup world, this conversation will teach you:Why venture capital doesn’t work for 99.9% of founders—and what needs to change.The three personality traits that separate great founders from the rest.How misaligned boards and outdated practices can derail even the best startups.At the heart of it all, Dan’s passion for connecting people, products, and processes shines through. As he says, “The next wave of commercial activity is about making money and doing good—it's not just about the bottom line anymore.”Curious for more? Listen to the full episode here and dive deeper into Dan’s bold vision and unfiltered perspective.Quotes:(3:44) "Most VCs have never worked in a startup, so how can they advise one?" (9:42) "The greatest founders are not just charming—they’re determined, disagreeable, and unrelenting in disrupting the status quo." (22:02) "We've moved on from 'don’t be a dick' to 'do some good'—and that’s how we transform the future."Timestamps(01:37) Bridging the Gap: Why Venture Capital Fails 99% of Founders (03:44) Startup Struggles: The Hard Truths Founders Need to Hear (09:42) Decoding Greatness: Traits of Exceptional Founders (12:58) From Prototype to Profit: Why Customer Obsession Wins (17:01) Boardroom Battles: Misaligned Boards and Startup Success (21:02) A New Era: Making Money While Doing GoodDon’t miss this chance to learn from Dan Bowyer’s dynamic journey, sharp insights, and inspiring approach to venture capital. Press play, and let’s spark some bold ideas together!Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
189
EP 150: 2024 in Review: 9 Bold Steps Toward a Brighter 2025
What makes a year unforgettable? Is it the challenges conquered, the bold ideas pursued, or the connections that shaped us?As 2024 comes to a close, this special episode celebrates the lessons, breakthroughs, and visionary insights that defined the year. Through 9 remarkable stories, hear from leaders, investors, and innovators who are shaping the future.🎙️ In This Episode:Suzanne Heywood: Discover the balance of trust and challenge that makes great leaders.Shlomo Noy: Explore how Israel transformed challenges into global innovation success.Charlie Munger: Learn why a latticework of mental models is the ultimate leadership tool.Hampus Jakobsson: Understand how empathy and diverse perspectives drive venture success.Marc Penkala: Uncover the mindset shift Europe needs to compete with U.S. venture capital.Jeff Bezos: Dive into the principles of customer-driven innovation from Invent and Wander.DC Palter: Find out why startups fail without the right mix of technical expertise and business acumen.Joe Panetta: Learn the secret sauce behind California’s thriving biotech ecosystem.Marina Schmidt: Reimagine food systems with agroforestry—a sustainable, resilient alternative to industrial farming.💡 Key Quote Highlights:“The ideal board member is a critical friend—someone who challenges you when times are good and supports you when they’re tough.” – Suzanne Heywood"Israel’s innovation story is a testament to how bold policies and restless minds can turn challenges into a thriving tech ecosystem." – Shlomo Noy“In Europe, we focus on what could go wrong; in the U.S., they focus on what could go right.” – Marc Penkala"A great product without the right team is like a rocket without a pilot—it won’t fly far." – DC Palter"Empathy isn’t just a soft skill—it’s a leadership superpower." – Hampus Jakobsson“Agroforestry isn’t just farming—it’s nature’s blueprint for a resilient, abundant food system.” – Marina Schmidt⏰ Timestamps:(00:00) This Was 2024 – 9 Stepping Stones into 2025(04:34) Suzanne Heywood: How Great Leaders Build Trust and Challenge(14:36) Shlomo Noy: How Israel’s Innovation Ecosystem Transformed Challenges Into Global Success(22:54) Charlie Munger – Poor Charlie’s Almanack: The Power of Thinking Across Disciplines(29:37) Hampus Jakobsson: Empathy, Fiction, and Business Success(37:31) Marc Penkala: Europe vs. U.S.—Bridging the Venture Capital Divide(45:13) Jeff Bezos – Invent and Wander: Solving Problems, Not Selling Tech(51:58) DC Palter: Why Great Inventions Fail Without Business Expertise(01:02:13) Joe Panetta: California's Risk-Taking Culture and Biotech Success(01:10:14) Marina Schmidt: Agroforestry—A Vision for a Sustainable Food System(01:22:17) Happy New Year 2025Step boldly into 2025, inspired by these stories of leadership, resilience, and innovation. The lessons of this year remind us that every small action today shapes a brighter tomorrow. Thank you for listening—here’s to a future filled with possibility and purpose.Stay curious. Stay hopeful. And above all, keep moving forward.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
188
EP 149: Marina Schmidt - How Do We Feed 10 Billion People Without Destroying the Planet?
Our global food systems are at a breaking point. Climate change, geopolitical tensions, and industrial farming are pushing us closer to food insecurity every day. Can we find a way to feed 10 billion people while safeguarding the planet?Marina Schmidt, founder of Red to Green Solutions, reveals groundbreaking ideas that reimagine how we grow, consume, and sustain food for a resilient future.🎙️ What’s in the Episode: 1️⃣ Building Food System Resilience: How to adapt agriculture to survive droughts, floods, and supply chain disruptions. 2️⃣ Passive Impact for Lasting Change: Discover how creating systems can drive sustainable results—even while you sleep. 3️⃣ The Global Food Paradox: Why efficiency in food systems comes at a cost, and how agroforestry could be the answer.👤 About Marina Schmidt: Marina Schmidt is the visionary Founder of Red to Green Solutions, the leading global podcast on food tech and sustainability. Ranked in the top 5% globally, Marina's work spans research, policy influence, and media, making her a trusted voice for transforming global food systems.💡 Quotes to Inspire: (06:38) "Food is not just sustenance; it’s a gateway to health and sustainability."(01:01:50) "Globalization makes food systems efficient but at the cost of stability."(01:12:20) "Agroforestry mimics nature, creating resilient ecosystems that feed both people and biodiversity."(01:50:19) "Food system resilience is key to surviving climate disruptions."(02:01:00) "Create systems for passive impact, change while you sleep." ⏰ Timestamps: (03:34) From Health Crisis to Food Sustainability(05:50) Transforming Health Challenges into Purpose(31:30) The Surprising Global Journey of the Potato(45:28) Vibrant Plate Colors and Nutritional Benefits(58:21) Globalization’s Impact on Food Systems(01:08:55) Fixing Farming Subsidies for Sustainability(01:15:35) Agroforestry: Nature-Inspired Food Systems(01:22:26) The Monsanto Legacy and Pesticide Debate(01:27:18) Why Europe Leads in Food Safety Regulations(01:35:52) Western Diets Reshaping China’s Food Culture(01:50:19) Building Resilient Food Systems for Climate Change(02:01:00) Creating Lasting Change Through Passive ImpactIf you care about food security, climate resilience, and innovative solutions that can sustain future generations, this episode is for you.🔔 Subscribe, comment, and share to help grow the show and bring more transformative ideas to leaders and changemakers like you.👀 Watch the full episode to uncover the tools and strategies that can redefine our food future—before it’s too late.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
187
Doerte Hirschberg: Investing in Climate Solutions and Transforming Industries (SPARK20 - 114)
What does it take to tackle the world's biggest challenge—climate change—while driving profit and innovation? Meet Doerte Hirschberg, a visionary investor reshaping industries with bold ideas and data-driven solutions.In this episode, Doerte takes us on a journey of how her team at Climentum Capital uses measurable CO2 impact as their guiding star. She shares insights into why the future of sustainable industries lies in rethinking systems, embracing new technologies, and focusing on the bigger picture. From transforming dairy into vegan alternatives to unlocking the potential of the hydrogen economy, her lessons are as inspiring as they are actionable.Whether you're an aspiring entrepreneur, an investor, or someone passionate about sustainability, this conversation will teach you:Why CO2 is the most powerful KPI to measure climate impact.How industries like food and transport are being revolutionized with technology like precision fermentation.The secret to avoiding overhyped trends while investing in solutions that truly make a difference.At the heart of it all, Doerte’s optimism, strategic mindset, and passion for innovation make this episode a masterclass in balancing ambition with sustainability. As she says, “The world doesn’t need more overhyped investments. It needs smarter ones.”Curious for more? Listen to the full episode here and dive deeper into Doerte’s remarkable journey. Quotes:(10:40) "We need to feed 7 billion people with less land, less animals, and less CO2—this isn't just a challenge, it's an opportunity to rethink the future of food."(17:26) "Imagine a world where climate change isn’t just a problem we talk about, but a challenge we’ve conquered—with measurable impact and real change."(14:01) "Biases are everywhere—even in venture capital. The industry claims it wants women, yet the system subtly works against them. It's time for that to change."Timestamps(0:00) Can We Balance Profit with Saving the Planet?(1:08) Why CO2 is the Key Metric for Climate Impact(3:07) The Challenges and Opportunities of Climate Tech(8:10) Why LPs Should Invest in Elemental Capital(11:12) The Future of Vegan Cheese with Fermify(14:01) Breaking Biases in Venture Capital(18:46) Vision for a Sustainable Future Don't miss this chance to learn from Doerte Hirschberg's journey, her inspiring vision, and her sharp strategies to reshape the future. Press play, and let’s spark some change together!Send us Fan MailJoin Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
186
#148: Think Long-Term, Thrive Always: 7 Lessons From Investing Titans
What if your greatest advantage in business was how you think about the future?In this episode, I explore Richer, Wiser, Happier by William Green, unpacking seven actionable lessons inspired by legendary investors like Warren Buffett, Charlie Munger, and Sir John Templeton. These lessons go beyond money—they’re about mastering long-term thinking, simplifying complexity, and building resilience to thrive in uncertainty.William Green, a journalist with decades of experience interviewing investing icons, distills their timeless principles into strategies for entrepreneurs, investors, and anyone looking to improve their decision-making.As an entrepreneur and investor, I’ve applied these lessons to my journey. From the power of focus to managing emotions and embracing change, this episode equips you with tools to sharpen your priorities, think strategically, and navigate today’s ever-changing landscape.Key Takeaways:This episode covers seven transformative lessons, including:Say No to Almost Everything: Focus on what truly matters and eliminate distractions.The Willingness to Be Lonely: Step away from the herd to achieve extraordinary gains.Resilience Is the Ultimate Strength: Prepare for downturns and thrive through tough times.Beware of Emotions and Ignorance: Manage emotional reactions and make informed decisions.Think Long-Term and Embrace Change: Play the long game to build lasting success.Simplicity Is Strength: Distill complexity into clarity for impact and growth.Success Is Built on Habits and Incremental Progress: Double down on what works and refine continuously.While this episode highlights actionable takeaways, Richer, Wiser, Happier dives even deeper, offering stories and frameworks that can transform your approach to business and life.Timestamps:(00:00) - Introduction: Why This Episode Matters(01:14) - The Book’s Relevance for Entrepreneurs and Investors(02:36) - Author Spotlight: William Green’s Unique Perspective(03:35) - Book Overview: Lessons Beyond Investing(05:17) - Key Takeaway 1: Say No to Almost Everything(10:39) - Key Takeaway 2: The Willingness to Be Lonely(15:12) - Key Takeaway 3: Resilience Is the Ultimate Strength(20:56) - Key Takeaway 4: Beware of Emotions and Ignorance(25:41) - Key Takeaway 5: Think Long-Term and Embrace Change(30:11) - Key Takeaway 6: Simplicity Is Strength(34:59) - Key Takeaway 7: Success Is Built on Habits and Incremental Progress(39:17) - Closing Insights and Final ReflectionsWhy Listen:Master Resilience and Focus: Build a mindset that thrives during challenges.Think Like a Legend: Apply strategies from iconic investors to your goals.Navigate Uncertainty: Gain tools to adapt and succeed in volatile environments.Actionable Insights: Practical coaching questions to reflect and grow immediately.If these lessons resonate, I encourage you to explore Richer, Wiser, Happier in full. It’s not just a book—it’s a guide to thinking better, deciding smarter, and building a resilient path to success.[Link to Amazon]Thank you for tuning in! Don’t forget to subscribe for more episodes where we uncover wisdom from the brightest minds in investing, entrepreneurship, and leadership. Let’s thrive together!Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
185
SPARK 20 - 109: Philipp Baaske, CEO of Nanotemper
What does it take to lead a global biotech company tackling diseases like cancer and Alzheimer’s—and still treat every team member, from executives to production staff, as equals?In this 20-minute highlight episode, we meet Philipp Baaske, the visionary CEO of NanoTemper. From his small Bavarian village roots to global biotech innovation, Philipp shares the leadership lessons and personal philosophies that shaped his journey.Quotes:(00:01:05) “Leadership is all about emotions. It’s not about you—it’s about your people. A leader is defined by their followers, and they follow because they trust and believe in you.”(00:04:19) “Complaining is just an excuse not to work on what you can change. Focus on improving instead.”(00:15:54) “Every month counts when fighting cancer. If we release a drug even one month earlier, we save lives.”Curious for more? Listen to the full episode here and dive deeper into Philipp’s remarkable journey. Timestamps:(00:00:00) Welcome to Spark20: Innovating Leadership(00:01:15) Top Leadership Lessons: Walk the Talk(00:02:33) From Bavaria to Biotech Visionary(00:06:01) Science Fiction & Physics: Philipp’s Inspiration(00:12:50) Launching to Space with NASA(00:16:00) Fighting Cancer: The Push for Better Tools(00:19:20) Leadership Challenges: Tough DecisionsIf you’re ready to discover actionable leadership insights, hear how innovation fuels impact, and learn why values truly matter in leadership, this is your episode. Dive into Philipp’s story, and don’t miss the chance to see how he turns bold visions into real-world breakthroughs.Listen now and be inspired.Send us Fan MailJoin Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
184
EP 147: DC Palter - Why Startups Face the 'Pit of Hell': The Truth About Securing Funding
Startups promise innovation, but why do so many fail to secure the funding they need?Investors demand results before committing, yet startups require resources to build. This paradox leaves founders stuck in what angel investor DC Palter calls the "pit of hell." How can startups navigate this critical gap and convince investors to bet on their vision?🎙️ What's in the Episode: 1️⃣ Cracking the Funding Code: Learn why most pitches fail and how founders can craft stories that eliminate investor doubts and inspire confidence. 2️⃣ The Angel Investor's Playbook: Discover how to manage long-term returns and why patience is critical in high-stakes investing. 3️⃣ The Climate Tech Challenge: Explore why building billion-dollar solutions demands more than innovation—it requires grit, strategy, and understanding the full business cycle.👤 About DC Palter: DC Palter is a seasoned venture investor, startup founder, and award-winning author. With 25 years of experience in tech, he bridges the worlds of business and storytelling. His expertise spans hard tech, climate tech, and helping startups succeed through mentorship, scrappiness, and vision.💡 QUOTES: (01:01:19) "The best pitches show why failure isn’t just unlikely—it’s impossible."(01:44:59) "Batteries are the key to unlocking sustainable energy solutions."(02:15:58) "The biggest challenge is investors want a finished product, but startups need funds to build."(01:19:52) "The best solutions don’t sell themselves; they solve real problems customers feel deeply."(01:16:48) "The CEO’s role isn’t just building products; it’s creating a sustainable business.⏰ Timestamps: (02:40) The Power of Storytelling in High-Stakes Business and Writing(11:49) Bridging Science and Business: The Role of Mentorship(17:31) Balancing Angel Investing and Flexibility(20:42) Shifting from Corporate to Startup Mindset(39:06) The Startup Funding "Pit of Hell"(45:49) Why Founders Must Pitch a $100M Vision, Not Just a Great Product(53:36) Crafting a Pitch Investors Can't Resist(01:08:58) Understanding Hard Tech: Beyond Invention(01:19:02) The Hard Work of Product-Market Fit(01:42:44) Batteries: The Key to Renewable Energy(02:05:44) The Global Privacy Paradox(02:19:48) The Long Game of Angel InvestingIf you’re ready to uncover the secrets of startup success, learn how to navigate hard tech challenges, and master the art of pitching, this episode is for you.👀 Stay Tuned: Watch the full episode to discover the tools, strategies, and stories that can transform your approach to investing and entrepreneurship.🔔 Subscribe, comment, and share to support the show and bring more transformative insights from leaders like DC Palter to light.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
183
EP 146: Bio Europe - Will Europe’s Biotech Future Survive? Inside the Funding and Talent Exodus
Europe’s biotech sector is facing a crisis: despite its scientific achievements, it struggles with funding gaps and an exodus of top talent to the US. As biotech innovations drive global healthcare, Europe risks losing its edge—and the potential for groundbreaking medical advancements that affect us all. How can Europe regain its competitive advantage and transform scientific discoveries into real-world solutions?In this special episode from BIO-Europe’s 30th anniversary in Stockholm, industry veterans Cormac Sheridan, Jonathan Smith, Christian Soschner, and Mike Ward reveal the path forward. They tackle the critical challenges in Europe’s biotech landscape, from funding shortfalls and talent loss to opportunities in AI and the promise of global partnerships. Discover the strategies that could redefine Europe’s role in biotech and keep innovation thriving on the continent.🎙️ What’s Inside:1️⃣ The Funding Dilemma: Why Europe’s investment landscape hinders biotech and how new models could change the game.2️⃣ Talent Exodus: How the brain drain to the US is affecting Europe’s biotech ambitions and what it takes to retain top innovators.3️⃣ AI in Biotech: Uncover the power of AI and digital tools in transforming drug development and patient care in Europe.4️⃣ Global Collaboration Opportunities: Why Europe needs to shift its focus eastward and the potential of partnerships beyond US borders.👤 Meet the Panelists:Cormac Sheridan: A seasoned biotech journalist, covering industry trends for over two decades, who reminds us that biotech’s success is rooted in resilience: “Fail faster, fail better.”Jonathan Smith: Biotech correspondent with insights into the complex regulatory and financial hurdles in Europe’s biotech ecosystem.Christian Soschner: CEO and biotech advisor, who shares powerful strategies on funding, partnerships, and global competitiveness.Mike Ward: Renowned analyst with a keen eye on market dynamics and investment trends shaping the future of biotech.Millie Nelson: Panel Host 💡 QUOTES:(05:18) "The future of biotech lies in integrating AI into medicine—beyond the hype." – Cormac Sheridan(00:17:22) "Failure is embedded in biotech. It's a risk-based enterprise; success demands resilience." – Cormac Sheridan(00:22:39) "and this brain drain when someone has a great idea that has..." - Christian Soschner ⏰ Timestamps: (00:00) Meet the panelists - industry experts with decades of biotech insight(07:15) Innovative funding paths and geopolitical impacts in biotech(06:30) Navigating Global Investment Challenges(00:16:07) Europe's biotech strength - powerful innovation, but struggles with commercializing scientific breakthroughs(00:22:39) Brain drain in Europe - how US incentives pull top talent across the Atlantic(00:29:06) Neuroscience breakthroughs - positive signs for neurodegenerative disease treatments spark new interest(00:34:08) Europe’s opportunity - global collaboration could drive biotech growth beyond US partnershipsJoin us as these experts explore how Europe can leverage its scientific heritage to remain a global biotech leader. This conversation is packed with insights on the future of AI, international partnerships, and what it takes to keep innovation alive in Europe.👀 Stay Tuned: Watch the full episode to see how Europe’s biotech ecosystem can thrive in the face of global competition and overcome its most pressing challenges.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
182
EP 145: Shlomo Noy - Why Healthcare Innovation Fails Without the Right Strategy
Healthcare investment is booming, but why do so few initiatives actually deliver lasting impact? While funding flows into biotech and life sciences, many leaders overlook the complex strategies needed to bridge research and real-world application. Are you ready to discover the key to successful healthcare innovation and make informed decisions that truly drive change?In this episode, Shlomo Noy, a pioneer in biotech investment and former VP of R&D at Sheba Medical Center, breaks down the secrets behind impactful investments in healthcare. From reshaping the DNA of institutions to aligning incentives for breakthrough results, Shlomo reveals the strategies that fuel successful innovation on a global scale.🎙️ What’s Inside: 1️⃣ The Art of Incentives: Discover how to balance researcher motivations with long-term institutional gains for innovation that sticks. 2️⃣ Israel's "Silicon Wadi" Secret: Learn how Israel transformed its natural limitations into a biotech powerhouse—and what other regions can learn from this approach. 3️⃣ Opportunities in China's Healthcare Market: Shlomo shares his insights on the untapped potential of China's rapidly growing healthcare sector, including strategic entry points for Western companies.👤 About Shlomo Noy: With over 25 years of experience, Shlomo Noy has led R&D at one of the world’s top-ranked hospitals and spearheaded healthcare investments worldwide. His expertise in aligning financial, clinical, and technological insights offers a rare, multidimensional view on successful healthcare innovation.💡 QUOTES: (00:08:14) "In life sciences, bridging finance with clinical insight isn’t optional; it’s essential."(00:29:39) "Transforming healthcare innovation requires reshaping the DNA of an entire organization."(00:41:02) "Our natural resource isn’t oil or gas—it’s the innovative minds of our people."(01:34:49) "China’s healthcare market is ready for innovation—and the opportunity is enormous."(02:12:54) "In the next 5-10 years, China's focus on women's health will redefine global markets." ⏰ Timestamps:(00:04:10) Shlomo Noy's Journey in Healthcare and Biotech Leadership(00:07:38) Multidisciplinary Teams: A Key to Biotech Investment Success(00:19:22) Protecting Researchers with In-House Tech Transfer Support(00:29:39) Transforming Healthcare: Changing the DNA of Innovation(00:38:36) Israel’s Silicon Wadi: The Biotech Innovation Boom(00:48:35) How Incentives Drive Institutional Tech Transfer Success(01:04:50) AI's Role in Drug Discovery and Patient Recruitment Challenges(01:20:02) China’s Healthcare Market: Uncovering Growth Opportunities(01:28:53) Clinical Trials in China: Scale and Efficiency Advantages(01:37:00) How Biotech Companies Can Navigate China’s Clinical Trial Landscape(01:53:03) Global Investment: Aligning Interests in Healthcare Innovation(02:17:13) Key Takeaways: Managing Innovation and China’s Healthcare MarketIf you’re ready to uncover the strategies behind impactful healthcare investments and explore new markets with confidence, this episode is packed with insights you won’t want to miss. Subscribe, comment, and share to help us bring more valuable content from leaders like Shlomo Noy.👀 Stay Tuned: Watch the entire episode to learn how to harness innovation, incentivize success, and navigate global healthcare opportunities.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
181
#144: 9 Life-Changing Principles from Charlie Munger: Smarter Investing and Decision-Making
What if you could rewire your thinking to solve life’s toughest problems? In this episode, we dive into Charlie Munger's timeless insights from Poor Charlie's Almanack, revealing 9 core principles for smarter investing, better decision-making, and a well-rounded life.Munger’s success is rooted in clear, simple principles that help avoid pitfalls and achieve long-term results. Poor Charlie's Almanack offers a unique blend of investing strategies, life lessons, and mental models that have shaped Munger’s extraordinary career.As an entrepreneur and investor, I’ve applied many of Munger’s lessons. In this episode, I break them down for you. From problem-solving through inversion to understanding cognitive biases, you’ll learn how to apply these principles to business and personal growth.Whether you're a venture capitalist, founder, or looking to improve decision-making, this episode equips you with the tools to build a strong foundation for success.Key Takeaways:This episode covers 9 transformative principles, including:Inversion Thinking: Simplify problems by thinking backward.Mental Models: Integrate knowledge from various fields for better decisions.Mastering Envy & Emotional Management: Develop resilience against destructive emotions.Compound Interest: See how consistent improvements lead to exponential growth.Biases and Cognitive Fallacies: Avoid common cognitive traps.Character and Culture: Build strong culture for long-term success.Munger’s Investment Checklist: Learn Munger’s method for picking winners.How to Fail in Life: Munger’s humorous guide on what not to do.Incentives in Organizations: Align incentives to avoid failure.Though this episode offers an overview, Poor Charlie’s Almanack contains much more. It’s a must-read for those looking to deepen their knowledge on investing and life.Timestamps:(00:00) Introduction(06:01) Portrait of Charlie Munger(11:00) Overview of Poor Charlie’s Almanack(18:21) Inversion Thinking(24:35) Mental Models(29:39) Ego and Emotional Management(36:51) The Power of Compound Interest(43:17) Biases and Cognitive Fallacies(50:52) Character and Culture(57:39) Munger’s Investment Checklist(01:08:00) How to Fail in Life(01:18:05) Incentives in Organizations(01:25:28) Key Takeaways(01:32:00) Reflection & ClosingWhy Listen:Master Problem-Solving: Learn how to simplify and solve complex problems using Munger’s inversion technique.Build Long-Term Success: Apply the power of compound interest and strong character to your business or investments.Avoid Common Pitfalls: Identify biases and cognitive traps that can derail decision-making.Actionable Insights: Munger’s investment checklist and character-focused advice will help you make smarter business and life decisions.If you’re interested in learning more, I encourage you to grab a copy of Poor Charlie’s Almanack. It’s a deep well of wisdom that can help you on your journey toward smarter decision-making, investing, and living.[Link to Amazon]Thank you for tuning in, and don’t forget to subscribe for more episodes where we explore the best strategies from leading minds in business and investing.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
180
EP 143: Jordi Ferrer Rendé - Is Healthcare Destroying the Planet? The Shocking Truth About CO2 Emissions
Artificial intelligence is revolutionizing healthcare, but what if the real danger lies in the industry's carbon footprint?Despite healthcare’s purpose of saving lives, the industry contributes up to 10% of CO2 emissions in developed countries. Can patient care and sustainability go hand in hand, or are we risking the planet's health for human survival?In this episode, Jordi Ferrer Rendé, Investment Director at Ship2B Ventures, reveals why healthcare's environmental impact is often overlooked and how intentional, impact-driven investing can reshape the future.🎙️ What's in the Episode:1️⃣ The Alarming Environmental Cost of Healthcare: Discover how healthcare contributes to CO2 emissions and what can be done to reduce them without compromising care.2️⃣ Preventing Problems Before They Happen: Learn how shifting investments from treatment to prevention could transform patient care and healthcare sustainability.3️⃣ Regulation vs. Consumer Demand: Understand why Jordi believes regulators, not just consumers, will drive the necessary changes for a more sustainable future in healthcare.👤 About Jordi Ferrer Rendé: Jordi Ferrer Rendé is the Investment Director at Ship2B Ventures, a European impact VC firm focused on transforming healthcare for chronic patients and the elderly. With over 12 years of experience, he is passionate about driving measurable social impact alongside financial returns, particularly in the areas of healthcare sustainability.💡 QUOTES: (00:21:39) "What if we invested in prevention rather than just treating diseases after they appear?"(00:39:12) "What if we measured healthcare’s CO2 impact? We could reduce emissions without compromising care."(00:56:21) "Consumers are pushing for change, but real sustainability will only come through regulation."(01:07:18) "Europe has incredible science and scientists at a very efficient cost – this is a place with huge potential."(01:53:04) "Success isn't just about ideas, it's about staying committed even through hard times."⏰ Timestamps: (00:04:00) Jordi Ferrer Rendé on the Power of Impact Investing in Healthcare(00:21:12) How the Healthcare System Prioritizes Treatment Over Prevention: A Dangerous Imbalance(00:37:30) The Alarming Truth: Healthcare’s Massive Contribution to CO2 Emissions(00:38:18) CO2 Emissions in Healthcare: 10% Contribution to Climate Change(00:56:21) Consumer Demand vs. Regulatory Power: The Future of Sustainability in Healthcare(00:58:59) How Investors Can Catalyze Sustainability in Healthcare(01:08:33) Europe as a Hub for Healthcare Innovation: Untapped Potential(01:33:00) Purpose-Driven Teams: Why Belief in the Mission Ensures Long-Term Success(01:43:06) Intentionality in Impact Investing: The Key to Understanding Founders and Their Purpose(02:02:41) Essential Advice for Aspiring Healthcare Investors from Jordi Ferrer RendéIf you’re ready to uncover the hidden environmental costs of healthcare and explore how impact investing can create a more sustainable future, this episode is a must-watch. Subscribe, comment, and share to help us bring more valuable insights from leaders like Jordi Ferrer Rendé.👀 Stay Tuned: Watch the entire episode to discover how healthcare can be transformed by focusing on prevention, sustainability, and impactful investments.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
179
EP 142: Angeli Moeller - Why AI Isn’t Transforming Healthcare Like It Should
Artificial intelligence is heralded as the future of healthcare, but why do so many innovations fail to make a tangible impact? Despite the hype, countless companies are missing critical opportunities to leverage AI effectively. What’s holding them back? In this episode, Angeli Möller, CEO of Sequoia Growth, reveals why healthcare AI often falls short and what leaders must do to turn potential into reality.🎙️ What's in the Episode:1️⃣ The Real Barriers to AI in Healthcare: Explore why many organizations struggle to integrate AI into their core business, and how to overcome these challenges.2️⃣ Unlocking True Innovation: Learn from Angeli’s experience at Bayer Pharma and Roche on why understanding the problem is the first step to meaningful solutions, not jumping on the latest tech trend.3️⃣ Building High-Impact Teams: Discover the critical role of diverse, specialized teams in navigating complex healthcare landscapes and driving sustainable growth.👤 About Angeli Möller: Angeli Möller is the founder and CEO of Sequoia Growth, a consultancy dedicated to bridging the gap between AI innovation and practical healthcare applications. With a background that spans senior roles at Bayer Pharma and Thomson Reuters, she’s a thought leader at the intersection of data science and healthcare, advocating for AI solutions that truly improve patient outcomes.💡 QUOTES: (31:08) "Leadership is not about knowing every detail; it's about having vision and empowering others."(55:31) “Success starts with choosing the right team—motivated, competent individuals who share your vision.”(01:11:43) “For any company that doesn’t find a way to make the right tool part of its core business, they risk losing to competitors who will.”(01:14:58) "The real bottleneck isn't the lack of algorithms or computing power; it's the lack of quality data."(02:03:38) "Do you deeply understand the problem you're trying to solve? It goes beyond what customers tell you they need."⏰ Timestamps:(04:31) Industry Experience as a Foundation for Career Growth(08:24) Embracing Berlin's Vibrant Culture and Innovative Spirit(17:41) Leadership is About Vision and Strategy, Not Knowing Every Detail(32:59) The Power of International Collaboration in Research(38:34) Redefining Leadership: Embracing Caregiving and Global Impact(50:15) Be Clear on Your Communication Style and Personal Boundaries(01:03:07) Biotech's AI Revolution: From Skepticism to Clinical Success(01:10:33) Beyond the Hype: AI's Practical Integration in Pharma(01:19:35) The Interplay of Data and Intelligence(02:02:46) Understanding Customer Needs is Key to Transforming Science into Impactful SolutionsIf you’re ready to dive deep into the real challenges of healthcare innovation and learn how to harness AI’s potential, this episode is a must-watch. Subscribe, comment, and share to help us bring more insightful content from leaders like Angeli Möller.👀 Stay Tuned: Watch the entire episode to uncover how companies can turn AI potential into impactful healthcare solutions and drive sustainable growth.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
178
EP 141: Alessandro Morra - How AI-Powered Robotics Will Transform Security—Are You Prepared for the Future?
Many companies today face increasing security challenges, yet few are leveraging the power of AI and robotics to protect their most critical assets. But what if these groundbreaking technologies could not only reduce costs but also provide a more efficient and secure future? In this episode, Alessandro Morra, CEO of Ascento, shares how AI-powered robotics are reshaping industries and why embracing this transformation is essential for future success.🎙️ What's in the Episode:1️⃣ AI & Robotics in Security: Discover how AI-driven robots are revolutionizing the way companies safeguard their outdoor properties, from manufacturing plants to data centers.2️⃣ Overcoming Challenges: Learn how Alessandro Morra navigated unexpected obstacles and breakthroughs, including viral moments that helped Ascento achieve product-market fit.3️⃣ The Future of Automation: Explore the next frontier of robotics and AI, and how these innovations will enable the workforce to focus on higher-value tasks.👤 About Alessandro Morra: Alessandro Morra is the visionary CEO of Ascento, a company specializing in AI-powered robotic guards designed to patrol large outdoor properties. His mission is to transform the security industry by leveraging the latest advances in robotics and AI to offer smarter, more efficient solutions to companies across sectors like manufacturing, energy, and luxury goods.💡 QUOTES: (41:01) "With robotics, we're just starting to scratch the surface of what's possible. "(50:46) "We found a great problem for our overly engineered solution, and that changed everything."(01:15:48) "We see robotics as a pivotal moment in innovation, and we're just getting started."(01:20:16) "Fundraising is like building a company - you need a plan to be profitable."(01:47:10) "We want to help the workforce of the future focus on what people do best."⏰ Timestamps:(10:10) From Zurich to Startup Success: Alessandro's Journey(11:40) How Ascento robots were created(29:28) How Robots Are Transforming Security and Reducing Costs(41:19) Unlocking the Future of Security with Robotics and Data(50:44) Viral videos: the unexpected boost that propelled Ascento forward(51:50) From Viral Videos to Focused Solutions: Ascento's Journey to Product-Market Fit(01:09:49) Expanding Beyond Borders: The Inevitability of Global Expansion(01:16:34) Ascento's Vision: From Security to Predictive Maintenance(01:27:01) "Fundraising is like dating - do your due diligence!"(01:44:40) Will robotics revolutionize human tasks in the next decade? Morra's vision for Ascento's futureBooks mentioned:The Power LawThe Hard Things About Hard ThingsInfluence CialdiniMeditationsIf you’re ready to explore how AI and robotics are transforming industries and ensuring a safer future, this episode is a must-watch. Subscribe, comment, and share to help us grow the show and bring you more groundbreaking insights from leaders like Alessandro Morra.👀 Stay Tuned: Watch the entire episode to discover how robotics can unlock new efficiencies and opportunities in security and beyond.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
177
#140: Customer Obsession Isn’t Enough—What Jeff Bezos Knows That Most Leaders Miss
What’s the secret to building a trillion-dollar company from scratch? In this episode, we uncover Jeff Bezos' game-changing strategies from Invent and Wander, revealing how Amazon became a global powerhouse.In the world of business and investing, visionary ideas alone are not enough. Invent and Wander reveals that it's a relentless focus on long-term thinking, innovation, and customer needs that differentiates industry leaders from the rest.Throughout my career, I’ve learned that building a company is not just about executing on today's goals—it's about building toward the future. Drawing on my experience as an entrepreneur and investor, I’ll break down the key lessons from Amazon’s journey to help you understand what it takes to create a business that thrives in the long term.This episode dissects 10 powerful principles from the book, offering insights into leadership, innovation, and decision-making. From leveraging technology to solve real customer problems to the art of long-term planning, we’ll uncover how you can apply these principles to your own ventures and investments.Book on Amazon:[Link to Amazon]Problems This Solves:Overwhelmed by complex business strategies? This episode simplifies Bezos' core principles into actionable insights.Unsure how to build a long-term vision? We’ll provide real-world examples and strategies for future-proofing your business.Curious how Amazon fosters continuous innovation? Learn how to stay ahead of the competition by focusing on what truly matters.Why Listen:Discover the 10 Key Principles for Success: Understand the strategies that turned Amazon into a global powerhouse.Learn from Real-World Case Studies: Explore examples like the Kindle and Alexa to see these principles in action.Apply Bezos' Insights to Your Own Journey: Gain practical takeaways to foster long-term innovation and resilience in your business.Quotes:"We will continue to make investment decisions in light of long-term market leadership considerations.""Listen to customers, but don’t just listen to customers—also invent on their behalf.""What’s good for customers is good for shareholders."Timestamps:(00:00) Introduction to the Episode – Tl;DR 1(03:49) Who is Jeff Bezos? – Tl;DR 2(09:52) Overview of the Book – Tl;DR 3(14:44) The Essential Character Traits of Founders(21:57) The Regret Minimization Framework and Goal-Oriented Planning(28:57) The Five Principles Behind Amazon's Success(37:16) Using Technology to Solve Customer Needs(42:55) Timeless Hiring Principles from the 1998 Letter(51:15) Embracing Moore's Law to Build Toward the Future(58:31) What Is Good for Customers Is Good for Shareholders(01:05:03) Constantly Investing in New Things with Clear Market Goals(01:11:45) The Kindle Case Study - Innovating by Working Backwards from Customer Needs(01:18:47) Listen to Customers, But Invent for ThemSend us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
176
EP 139 - Marc Penkala - Why European Startups Must Think Bigger: Lessons from a Top VC on Turning Failure into Fortune
Many European startups are trapped in a mindset that limits their potential, aiming for millions when they should be thinking in billions. But what if this conservative approach is holding them back from global success? In this episode, Marc Penkala, a leading venture capitalist, reveals the secrets to breaking free from this limiting mindset and how embracing calculated risks can lead to extraordinary rewards.🎙️ What's in the Episode: 1️⃣ Mindset Shift: Learn why European startups need to aim higher and adopt the billion-dollar mindset that drives U.S. success. 2️⃣ Contrarian Strategies: Discover the power of going against the grain in venture capital—why the best deals often come from the least obvious places. 3️⃣ The Role of Failure: Understand how embracing failure as a crucial learning tool can pave the way for long-term success in both entrepreneurship and investing.👤 About Marc Penkala: Marc Penkala is the driving force behind Altitude Venture, Europe’s first SME Tech Fund. With a wealth of experience as both an entrepreneur and investor, Marc is on a mission to revolutionize the European startup ecosystem by challenging traditional norms and pushing for bigger, bolder ambitions.💡 QUOTES: (01:13:14) "European startups think in millions, while U.S. startups think in billions—think bigger." (01:19:01) "In Europe, we focus on what could go wrong; in the U.S., they focus on what could go right." (01:40:50) "The best companies are created in down markets where money is scarce, and innovation thrives." (01:07:48) "The more often you're wrong, the higher the actual output of your fund."(00:43:34) "When the tourists arrive, you should leave."⏰ Timestamps: (00:07:05) Lessons from Early Entrepreneurial Ventures(00:14:31) The Reality of Entrepreneurship: Embracing Failure and Persistence(00:19:26) The Tough Decisions in Venture Capital: Investing vs. Divesting(00:26:30) Building Relationships: The Key to Successful Fundraising(00:34:30) Unveiling the Full Picture: The Business of Guiding Emerging Funds(00:39:03) Choosing the Right People to Journey With(00:43:08) Timing is Everything: The Importance of Market Dynamics in VC(00:43:34) The "Tourists" in Venture Capital: Recognizing Market Exuberance(00:51:26) The Untapped Potential of the SME Tech Market(00:53:32) Fundraising in a Down Market: The Power of Relationships(01:03:33) Is Europe Ready for Mega Funds or Better Suited for Micro Funds?(01:13:13) Think Bigger: The Difference Between US and European Startup Mentalities(01:21:35) Risk Aversion: The Key Difference Between European and US VC(01:31:37) Fostering European Innovation: Overcoming Challenges and Seizing Opportunities(01:38:10) The Importance of a Long-Term Vision in Venture CapitalIf you're ready to rethink your approach to startups and venture capital, this episode is a must-watch. Subscribe, comment, and share to help us bring more insightful content to you for free.👀 Stay Tuned: Watch the entire episode to unlock the strategies that could transform your startup's trajectory and help you achieve extraordinary success.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
175
#138: The PayPal Blueprint: How Vision Without a Business Model Nearly Sunk a Tech Giant
Ever wondered what it takes to build a tech giant from the ground up? Is it just about having a great idea, or is there a secret formula for success? In this episode, we dive into Jimmy Soni's The Founders, uncovering the key principles that propelled PayPal from a fledgling startup to a cornerstone of the digital economy.In the world of investing and entrepreneurship, having a visionary idea is just the beginning. "The Founders" reveals that it’s the combination of vision, timing, and an unrelenting focus on execution that separates successful companies from the rest.Throughout my career, I’ve learned that building a business is like solving a complex puzzle. Each piece—whether it’s hiring the right people, navigating market challenges, or building a sustainable business model—needs to fit perfectly. Drawing on my experience as an entrepreneur and investor, I’ll break down the stories and strategies from PayPal’s early days to help you understand what it really takes to create a company that lasts.This episode dissects 10 crucial lessons from the book, each one offering valuable insights into leadership, innovation, and resilience. From taking calculated risks and building trust, to the power of culture and strategic partnerships, we’ll explore how these principles can help you build a winning team and a sustainable business.Book on Amazon[Link to Amazon][Interview with Jimmy Soni]Problems This Solves:Overwhelmed by the sheer volume of business books? This concise summary delivers the most impactful lessons from "The Founders."Unsure how to translate entrepreneurial principles into action? We'll provide actionable takeaways and reflection questions to guide your journey.Curious about the minds behind PayPal and its lasting impact? Gain insights into the challenges, strategies, and collaborative spirit that fueled their success.Why Listen:Discover the 10 Lessons for Success: Uncover the strategies that turned PayPal into a tech powerhouse.Learn from Real-World Examples: Hear stories from the book and my own experiences that illustrate these principles in action.Apply the Lessons to Your Own Ventures: Reflect on how you can foster innovation and build a resilient business.Quotes:“On the eve of its IPO, a prominent trade publication declared that the country needed PayPal ‘as much as it does an anthrax epidemic.’”“Properly understood, PayPal’s story is a four-year odyssey of near-failure followed by near-failure.” "PayPal started off as a product with no use case. Then we had a use case but no business model. Then we had to build a sustainable business.""Your life will be shaped by the things you create, and the people you make them with." Timestamps:(00:00) Intro(03:03) Jimmy Soni(06:28) Overview of the Book(10:42) Vision, Persistence, and Hiring the Right People(17:08) Elon Musk's Bold Moves: Risk and Reward(23:07) Peter Thiel's Contrarian Thinking: Market and Monopoly(30:20) Max Levchin’s Obsession with Security: Building Trust(35:36) PayPal's Viral Growth: User-Centric Design(41:54) Surviving the eBay Wars: Strategic Partnerships(48:10) The IPO and Beyond: Timing and Execution(54:00) The Role of Culture: From Chaos to Cohesion(59:42) PayPal Mafia: Legacy and Impact(01:05:30) Entrepreneurship Challenges: Navigating Uncertainty(01:11:12) Wrap-Up and Key Takeaways(01:13:30) Epilogue: Life AdviceSend us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
174
EP 137: Hampus Jakobsson - The Secret to Venture Success: Investing in People, Not Just Ideas
Did you know the secret to venture success isn't just in groundbreaking ideas? It's in the people behind them. Learn how empathy and grit fuel extraordinary success in this insightful episode. Many investors fail by only chasing ideas. Discover why focusing on the right founders can unlock revolutionary outcomes. Join us as Hampus Jakobsson reveals how empathy and grit are the true drivers of innovation and success. Most investors miss out on potential unicorns by focusing only on concepts. What if the real key to revolutionary success lies in the unique qualities of the founders? 🎙️ What's in the Episode:1️⃣ Empathy and Grit: Learn why these traits are essential for founders aiming to make a significant impact.2️⃣ Market Understanding: Understand the importance of having a clear vision for the future and how it influences investment decisions.3️⃣ Investing in Resilience: Discover why Hampus Jakobsson focuses on people who are not just smart, but incredibly resilient and unconventional. 👤 About Hampus Jakobsson:Hampus Jakobsson is the co-founder of Pale Blue Dot, a venture capital fund focused on climate tech innovation. He believes that the future belongs to those who think differently and have the resilience to turn their unconventional ideas into reality. 💡 LINKS TO MORE CONTENT Christian Soschner💡 Quotes:(09:58) "Reading fiction builds empathy, allowing us to experience the world through others' eyes."(28:45) "Any time in life I've been the smartest person in the room, I usually try to find other rooms."(00:57:35) "The mobile industry missed innovation due to medieval-like alliances and rigid structures."(01:03:01) "Innovators and entrepreneurs drive progress; managers often stifle it by prioritizing efficiency."(01:50:49) "The greatest founders combine empathy and grit to navigate the toughest challenges." ⏰ Timestamps:(02:00) Mastering Multiple Accents and Languages(07:00) The Power of Fiction and Top Podcast(09:49) Building empathy through fiction's diverse perspectives(11:27) Imagining the future: mind uploading and lunar economy(17:53) Authenticity vs. Performance: The Inner vs. Outer Self(21:39) Bitcoin: A Catalyst for Metaphysical Conversations about Value(27:02) Explore vs. Exploit: Balancing Algorithmic Strategies for Growth(30:57) The Burning Library: Empathy and the Destruction of Knowledge(38:15) The Turning Point: From Arts to Mobile Technology(40:44) "The Birth of the Business Card: A Humorous Tale of Entrepreneurial Resourcefulness"(43:46) Landing a Major Client by Chance(52:44) Samsung's Speed to Market Philosophy: Thriving in a Fast-Paced Tech Environment(53:41) Competing Giants: Motorola, Samsung, Sony Ericsson, and Nokia's Battle for Supremacy(57:35) Market Saturation and Innovation: What the Mobile Industry Missed(01:03:00) Steve Jobs' Philosophy: Wasting Time in a Great Way(01:09:07) Apple vs. Google: Contrasting Paths to Innovation(01:12:00) Pride and Passion: The Secret Sauce of Successful Companies(01:16:00) Building Trust and Relationships: A Venture Capitalist's Perspective(01:19:01) Finding the Right Founder-Investor Relationship(01:20:08) Investing in the Extraordinary(01:28:00) Investing in extraordinary people and their unconventional visions(01:36:00) The drive to win is essential for great entrepreneurs(01:28:00) The Used Socks to Rocketship Analogy(01:39:00) The Importance of Research(01:38:00) From Creative to Scaling Mindset(01:50:00) Luck Favors the Prepared(01:54:50) Embracing Failure and Resilience(01:58:01) The Contrarian Mindset in Venture Capital(01:46:00) How to Identify ProSend us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
173
EP 136: Focus and Determination: Lessons from Dan Brisse's Sports and Business Career
Discover how Dan Brisse, a former X Games gold medalist, transformed his passion for snowboarding into a thriving real estate empire. In this episode of [Podcast Name], we delve deep into Dan's journey, exploring the resilience, focus, and determination that propelled him from professional sports to building Granite Towers Equity Group.🎙️ What's in the Episode: 1️⃣ The Power of Resilience: Learn how Dan's sports background instilled a never-give-up attitude, crucial for navigating the ups and downs of real estate investing. 2️⃣ Focus and Determination: Discover the importance of unwavering focus and determination in achieving success, whether in sports or business. 3️⃣ Passion-Driven Success: Understand how Dan leveraged his passion for snowboarding to fuel his entrepreneurial journey, turning challenges into opportunities.👨💼 About Dan Brisse: Dan Brisse is a former professional snowboarder and X Games gold medalist who transitioned into real estate investment. As the co-founder of Granite Towers Equity Group, Dan now focuses on multifamily investments and creating sustainable income streams for investors.💡 LINKS TO MORE CONTENT Christian Soschner📌 Quotes: (00:04:15) "Creating multiple income streams through real estate transforms challenges into opportunities." (00:28:07) "Certainty comes from thousands of reps; it's like walking, not a leap of faith." (00:37:08) "Commitment means doing what's necessary without backing down, even when facing major setbacks." (01:06:32) "To win the game of business, you need to know and play by the rules." (01:36:55) "As long as we can get through the next six months with cash flow, we'll thrive."⏰ Timestamps: (00:01:00) Discover the Secrets of Multifamily Investment Success (00:06:00) Insights on Inflation, Interest Rates, and Real Estate (00:12:02) From Passion to Profession: Dan's Snowboarding Journey (00:18:13) Hard Work and Dedication: Life of a Pro Snowboarder (00:21:11) "Overcoming Limits: The Reality of Top-Tier Snowboarding" (00:27:00) "Balancing Risk and Family: A Professional Snowboarder's Journey" (00:31:33) The Importance of Starting Early in Competitive Sports (00:35:08) Overcoming Major Setbacks to Achieve Success (00:43:15) The Importance of Defining Success for Goal Achievement (00:49:38) True Passion vs. Novelty: Differentiating Between Real and Fleeting Interest (00:52:09) Overcoming Boredom by Setting New Goals (00:56:12) Transitioning from Snowboarding to Real Estate Investing (01:06:11) Embracing Freedom in Real Estate Investment (01:12:19) The Importance of Education and Confidence in Investing (01:18:23) Real Estate Investment Strategy for Passive Income and Investor Partnership (01:23:11) Challenges and Lessons from Real Estate Investments During Volatile Markets (01:30:57) Understanding Real Estate Emotions and Market Reactions (01:36:32) Securing Cash Flow and Riding Market Cycles (01:44:28) The Discipline of Saying No in Investing (01:45:47) Learning from Pain: The Path to Successful Investing📣 Call to Action: If you’re inspired by Dan Brisse's journey and want to learn how to harness resilience, focus, and determination for your own success, this episode is for you. Subscribe, leave a comment, and share this podcast. Your support helps us bring more insightful content to you for free.👀 Stay Tuned: Watch the entire episode to uncover the full depth of Dan Brisse's remarkable journey.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
-
172
#135: Empowering Innovators: 10 Lessons from The Innovators by Walter Isaacson
Ever wondered how the digital revolution came to be? Was it the work of lone geniuses, or was there something more at play? In this episode, we delve into Walter Isaacson's "The Innovators," uncovering the collaborative efforts and key principles that have shaped our technological landscape.In the world of investing and entrepreneurship, building a multidisciplinary mental model is key to success. "The Innovators" reveals that diverse, collaborative teams have historically been the driving force behind groundbreaking solutions.In my martial arts days, a coach taught me to study exceptional role models – a strategy akin to the famous Harvard Business Cases. Analyze success, discover core principles, then adapt them to your own unique path. After all, as Bruce Lee said, "Absorb what is useful, reject what is useless, and add what is essentially your own."That's the lens I bring to biographies – extracting valuable lessons amidst the complexities of each individual story.This episode dissects 10 crucial tools for fostering innovation, drawing on stories from the book and my own experiences as an entrepreneur and investor. From visionary thinking and customer-centricity to the power of persistence and collaboration, we'll explore the strategies that can help you identify winning teams and create an environment where innovation thrives.Book on Amazon[Link to Amazon]Problems This Solves:Overwhelmed by history books? This concise summary delivers the most relevant insights for entrepreneurs and investors.Unsure how to apply innovation principles? We'll provide actionable takeaways and reflection questions.Curious about the minds behind the digital age? Gain insights into the collaborative spirit that drives technological progress.Why Listen:Discover the 10 tools for innovation: Uncover the strategies that have fueled successful collaborations and groundbreaking technologies.Learn from real-world examples: Hear stories from the book and my own experiences that illustrate these principles in action.Apply the lessons to your own ventures: Reflect on how you can foster innovation and build winning teams in your own organization.Quotes:"Creativity is a collaborative process. Innovation comes from teams more often than from the lightbulb moments of lone geniuses." - Walter Isaacson"The best way to predict the future is to invent it." - Alan Kay (as quoted in "The Innovators")Timestamps:(00:00) Intro(04:18) Walter Isaacson(08:21) Overview of the Book(12:28) Tool #1: Ada Lovelace and the Power of Visionary Thinking(18:01) Tool #2: Collaborative Teamwork(23:13) Tool #3: Craftsmanship(29:00) Tool #4: The Entrepreneurial Spirit and Culture of Innovation(35:32) Tool #5: Leadership that Breeds Innovation(42:13) Tool #6: Persistent Innovation(47:19) Tool #7: Public Awareness and Advocacy(53:48) Tool #8: Customer Centricity(58:51) Tool #9: Technicians Collaborating with Business People(01:03:20) Tool #10: Building Collaborative Ecosystems(01:07:55) Key Takeaways(01:14:00) Tl;dr Episode SummarySend us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
TOPICS IN THIS SHOW
Loading reviews...
ABOUT THIS SHOW
Blueprints for Builders and InvestorsHosted by Christian SoschnerFrom pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech—lives or dies by the frameworks it follows.On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds.With over 250 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast. With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:What it really takes to turn breakthrough science into business—how to grow it, lead it, and shape the world around it.
HOSTED BY
Christian Soschner
CATEGORIES
Loading similar podcasts...